var title_f3_12_3264="Shirodkar cerclage";
var content_f3_12_3264=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67778&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67778&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 556px\">",
"   <div class=\"ttl\">",
"    Shirodkar cerclage",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 536px; height: 388px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3264=[""].join("\n");
var outline_f3_12_3264=null;
var title_f3_12_3265="Chickenpox oral 1";
var content_f3_12_3265=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oral manifestation of varicella (chickenpox)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3265=[""].join("\n");
var outline_f3_12_3265=null;
var title_f3_12_3266="Patient information: My child is short (The Basics)";
var content_f3_12_3266=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?30/58/31650\">",
"         Patient information: Early puberty (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/26/17826\">",
"         Patient information: Growth hormone treatment (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/31/13810\">",
"         Patient information: Late puberty (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/1/30738\">",
"         Patient information: Normal sexual development (puberty) (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: My child is short (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/my-child-is-short-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H6634678\">",
"      <span class=\"h1\">",
"       How do I know if my child is shorter than normal?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your child&rsquo;s doctor or nurse will tell you. He or she will measure your child&rsquo;s height. Then he or she will compare your child&rsquo;s height to the height of other children who are the same age and sex. If your child is much shorter than other children of the same age and sex, doctors call it &ldquo;short stature.&rdquo;",
"     </p>",
"     <p>",
"      The doctor or nurse will measure your child&rsquo;s height at each visit. That way, he or she can follow your child&rsquo;s growth over time to track his or her progress.",
"     </p>",
"     <p>",
"      Normally, children grow a lot in the first 2 years of life. Then their growth slows down until they go through puberty. Puberty is a term for the changes in the body that happen during the pre-teen and teen years. During puberty, children grow a lot in a short amount of time. This is called a &ldquo;growth spurt.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6634693\">",
"      <span class=\"h1\">",
"       If my child is short, does it mean he or she has a medical problem?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Probably not. Many children who are short are healthy and do not have a medical problem. These children are short because:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        One or both of their parents are short. If a child&rsquo;s parents are short, chances are good that he or she will be short, too.",
"       </li>",
"       <li>",
"        They are growing more slowly than normal. Doctors call this &ldquo;growth delay.&rdquo; These children are short because they have their growth spurt later than other children. But these children will grow to a normal height as adults.",
"       </li>",
"       <li>",
"        They had a growth spurt at a younger age. Some children grow quickly when they are young and go through their growth spurt early. For a while, they are taller than other children their age. But then other children catch up to them and grow taller.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some children who are short do have a medical problem. Different problems and conditions can cause children to be shorter than normal. Some of these include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Being very thin",
"       </li>",
"       <li>",
"        Long-term conditions that affect the digestive system, heart, lungs, kidneys, or blood",
"       </li>",
"       <li>",
"        A condition called &ldquo;growth hormone deficiency&rdquo; &ndash; People with this condition have too little growth hormone in their body. Growth hormone is a substance made in the brain that helps children grow normally.",
"       </li>",
"       <li>",
"        Problems that babies are born with, caused by abnormal genes",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6634708\">",
"      <span class=\"h1\">",
"       Will my child need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. The doctor or nurse will want to know why your child is shorter than normal. He or she will talk with you and ask about the growth and heights of other family members. He or she will examine your child, and might also do:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood tests &ndash; The doctor can check for different conditions, including growth hormone deficiency.",
"       </li>",
"       <li>",
"        X-rays of 1 of your child&rsquo;s hands and wrists &ndash; Doctors can use these X-rays to help tell how tall your child will grow.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6634725\">",
"      <span class=\"h1\">",
"       Will my child need treatment?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It depends on why your child is short. If your child is short because of a medical problem, your doctor might be able to treat it.",
"     </p>",
"     <p>",
"      Doctors treat growth hormone deficiency in children by giving them growth hormone. Growth hormone treatment usually involves getting a shot of the hormone every day for many years. Children who get growth hormone treatment need regular follow-up blood tests.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6634740\">",
"      <span class=\"h1\">",
"       Is growth hormone treatment ever used for children without growth hormone deficiency?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Not usually. That&rsquo;s because:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Growth hormone treatment doesn&rsquo;t always make children grow. Even if growth hormone does make a child grow, he or she will only grow 2 to 3 inches (4 to 6 cm). A short child will not become tall with growth hormone treatment.",
"       </li>",
"       <li>",
"        The treatment costs a lot of money and is not easy. Children usually need to get a shot every day for many years.",
"       </li>",
"       <li>",
"        Being short isn&rsquo;t usually a problem for children and doesn&rsquo;t keep them from having a normal, happy life.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6634755\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to help my child?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Make sure your child gets enough food and eats a healthy diet. If you need help changing your child&rsquo;s diet, ask the doctor or nurse.",
"       </li>",
"       <li>",
"        Help your child feel good about him or herself. Try to point out your child&rsquo;s strengths and not focus too much on his or her height.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H6634770\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/1/30738?source=see_link\">",
"       Patient information: Normal sexual development (puberty) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/31/13810?source=see_link\">",
"       Patient information: Late puberty (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/58/31650?source=see_link\">",
"       Patient information: Early puberty (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/26/17826?source=see_link\">",
"       Patient information: Growth hormone treatment (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?3/12/3266?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16736 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-89768E4622-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3266=[""].join("\n");
var outline_f3_12_3266=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6634678\">",
"      How do I know if my child is shorter than normal?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6634693\">",
"      If my child is short, does it mean he or she has a medical problem?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6634708\">",
"      Will my child need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6634725\">",
"      Will my child need treatment?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6634740\">",
"      Is growth hormone treatment ever used for children without growth hormone deficiency?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6634755\">",
"      Is there anything I can do on my own to help my child?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6634770\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/58/31650?source=related_link\">",
"      Patient information: Early puberty (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/26/17826?source=related_link\">",
"      Patient information: Growth hormone treatment (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/31/13810?source=related_link\">",
"      Patient information: Late puberty (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/1/30738?source=related_link\">",
"      Patient information: Normal sexual development (puberty) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_12_3267="Schematic LV free wall accessory pathways";
var content_f3_12_3267=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F76316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F76316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Schematic showing anatomic locations of accessory pathways in the left ventricular (LV) free wall",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 345px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Longitudinal cross section of the free wall of the left ventricle at the level of the atrioventricular (AV) groove. The accessory pathways are present in the AV groove fat pad at variable depths in relation to the mitral annulus and the epicardium overlying the AV groove.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3267=[""].join("\n");
var outline_f3_12_3267=null;
var title_f3_12_3268="2D TTE Parasternal short axis coronary arteries";
var content_f3_12_3268=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54573%7ECARD%2F79123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54573%7ECARD%2F79123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Two-dimensional transthoracic echocardiogram (2D TTE) from the parasternal short axis view at the level of the coronary arteries",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 260px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The origins of the right (RCA) and left (LCA) coronary arteries can be seen on the short axis precordial view, obtained through the aortic root (Ao) just above the valves; there is a vague \"pinwheel\" relationship of the sweep of the arteries. Additionally, the left atrial appendage (LAA) is seen just inferior to the LCA and the pulmonary valve (PV) just superior.",
"    <div class=\"footnotes\">",
"     LA: left atrium.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Short axis view of left main coronary artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 203px; height: 296px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEoAMsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5VoooqgAUtIKUfrQtgEpT7UUdTigA7Uu4eXtIOc9c0hGDg9qD2pXASiiigBaTtS0lABS9u1AGaB64ouAHpShivKkj6Gk7fzo9sDIpCOs8P+NdW0lfJh1KWOAJhQsSnb+ma9h8O3Fx4l0u3uNZ1S5SxyCHMu2SQjjOB0r5yH0zXS6Nf6jawI0cr2tnn5ZWG7HsBRKN0S49j6EsLnw/a60kOm/21rd6o2KsBMcSZ/vOSM1z/wAQPiFf2Ed9oFlaiKWNQkrxjf5RPJG7ufU15zJ8QfENjZPbWF/bRwthWlhiCsp/LOadNrl3eaXFpdrdvI1yN09w9tjec5OGxk1ly9QSstTIudNB0oardC4VJciNBwZG9T3x3rmZLeWGJZZoiEkB25PP1xXfaHoE+vTmC81SeZY8rFEinccevtWL4h06DT7i8S+kmmnTEcS9Ap9z3rVNLRhfWxydIacR64FN6VV7lhSUtFJgFFFFMAooooAWlXHQ/maVVBUncN3pinxIJGWP5VJ43E8Z96Qh6HzIRDtXzAeHyenpjpVibSbyFVaSMAOMqd3Ue1dH4M0TU2vpHXT4760hOJ4mweP7w/xFem/8I5pNzYW0strJAY3Dqu7MUg/u+xpOSIcrOx4C6MhwysPqKaemDX0xL4B0bxIRa2NykbuAxglg2PCQP4W6EfjXknj34c3/AIWkdndJoy+Bs5IHbPvT0fUFO+5wNFOYEHGMYpDnn1pWNAHvSEUvuDQaYB64oPJGKB+dLnGCDgigBM+tWIJWVkLOWiiYNsLYz9Kr9Tk07J2hSo9c45ouI1Zp5dRvRNbWQj2r0iTOfc56muig1jxBaaepe4S2gA2CWZF3D2AxkVylvql3axhYJ3Qj9B6VqR6tZyWLCe3e71JxzLcP+7j9wPpSaJaJrLV/EKvJNZ3Usccp2GYER78+9Z+r7WiBmv2ubxW+ZVUkL65Y9TUd41xLp8cs0xkjzhRuwF/3RVjdBFoOJbvdM/Kwxr092NCSWozEbO70PvTnjKqGYgE9u9S7VgQ7wGlYcD+79feopOvLBm7kVQyKinEYxTaTGLRmnAce/wCVJxweaAEpRxQMk5ox6UAOABU/3u3HWpbWLz5VRAC2fu9C3sKjRfMYKCAT07VcjsniVJHcRkH7ytyp9x1oQjuPBPjOPRZfsWpKogRSkdwi4mi/2T2YfWurHjCN0SC1ubG5infCxyjZuJ9R2PvXlVkiwXbNdRLfQum4gcsPcVmySomoeZaKY1D5UMOlQ4JvQXKmfXPgiw01o7f7XdRi927QJGPyr/cBHUe9djqngXTNbcJfQDyiMEpIW3ehAr5m0n4i6QumINTsJV1GFQFkgP38fjwK7bwd8boYrsS3zXVtGE2iLbujYDoc+tR7yd2ieS+jIviz8E7LSEiuNJu4reKQ42yklmPoBXz/AKrYS6bfzWk4O+NsEkEZr6+l+LXgXxSsMGoPO0sbB0kSAlkauM+JvgdvF119u8P2V9f7x8oiiCYHqSetaQqXeoP3PQ+Zz1pTyCRx610niXwjqWg5N9AYMsQsLHLjHqBXN4JBODx1q2rlJpgAT0Hag9DXrnwR+G2k+NrLWLrVpNVlNrNFaxW2mRq0gMuQJW3fwLjJ9q7U/Bvwno9sdV1fUHuNG0qC6tdWuUkIBv1cLGEXrjnkeoHrRoldsTlrsfN6bc/MCeP1oG0BgwJbt7Us23znK427jj6Vv6LZaaltLLrS3I43RpGnDD/epIq/Ux4ELW5McO592A3X8MUR2M817HbBUWWQ8AsAB/hV25uNMDN9gW6gBHds81ViWGUIiu4nJ+92FFwNaLQYWu47E36XF2Gw8cPIUezHgmpNbs4NIPl2exbhD8xY7mX+lY8NnOuo+RbSKJV53h8Acdc0y8jJumRZmuJOsjds98E9aWt9WFtSOV3JSRwDk5z3b60I0byb5iygHoowTS23lEsJn2AchgNxx6U+6e3ZMWyMEBGXc8mqTEyo+N5xwCeM1PDHC0YLuA3cYP8AhUDdT3qRANo5/wDHacRsi9DSryQKQjHWlA/wqWMVff8A+vTT+lL39u1HP+FAiQwyeT5yqxizgsOx961NJkidQkoNyTx5IXDj3B7/AEqHR45ZkmSNBKu3LLnOPfFQyvBErLGkkc6n5WBIx60g8hb9lhuj9ink8sE7Qchl9QapFiWznDetSqJrqWONA8krsFUDksxPAHvXda/8KPEmkeKdI8M/ZEuda1GITQxwPuUqQScscAbcHPYYzTsBw5XzPL/1aM38Zbj8fSrVxFfaaE88fu2+7nDKw9q6nxz8MfEfgbToNR1aO0nsZ5Tbi4tJxNGsozujcjowKsPqp9K5aPUjJbLZ3YU2w4XA5j9xQwdyol3Kk3mxyNE2c/u+MV9PfA34h6rc20FhLqAmtok2GRvlZSOzV8uzIqTMInEiA/K2OortPh9daOJ0hvpLm0uByZo3YI49GAqZRugZ9GfGG50+4077Z4ltI3gwBHdWKhpQD2bHPPevlzX7d47meSztJYNPnbMO9CGZe1fU3hT+yLmOGeGD7VGV27Fk3rLjvhjW7qOt+G3eJ9dsbTT4Ysxol1CuAR0wRUxmluzPbU+bfgtqWs3GrDwVpup/2Lb+ILlPtF/HuSeIRBm2owIxuHGPU/Wqvi/xLJodx4j8E6Xfz6h4R/tJpCtxjzZZUwC+/GeWXPvjNdV8aNd8I3zqvhERSavvGbi1iKYHfB7GvK9Mlto7zOs2klwpByI1+YH1J71UUpO5XMzLt5II7kvNAZY/4Yy2M+mTT72+a4kYIpggPIhRiVWn6l9jeUtYeeSzH5HXoKvSeG9Qj0+O5a0mRHXeJGwFI9qp6jMjazKsaIu49McsadGFjZ1nDIV646/Sm7zFc7ocxlTgYPIpHWR5vny8j888k0blD2MTOxQGKPGABySadDtMDoPLDHjc3UCpoja2omS5gMk23CkNwD9KzzTYXJjbNglPmUfxdAfpUskMCIoaU7+rYGRj2qDzHIQOWZF6DsKazl2yc59u1O4mI+AxCkle2aSgnJzRjPekvIYUuKT86UDI9vXFJgHX60o68AHHb1pyxsY2dR8q9eRn8qZxjnmkI6CHT5vssN7ZiN4nID+W+0hvTB5FY1/5n2uQzhg5OTuGDTYp5rZt0TsmR27imSSPI+93LMe560K63A6z4Va7pPhnx1pusa7YzahZWe+TyIQCzSbTsPJAwGIP4d69Zt/jrpM+p+DNc1HSbga1pc91Fei2H7t7acNxGxbdvXKnBwODg88fPGPlzkfSk/Shq4z1/wCIvjLwsnw/Twd4HTUZ7WbU31S8u75NjbjkLGoyeQCoJ77O+a8gJ6+9KGYkck49TQcE8cZ/SjyEJg4z2rQsHuIbeSe3ZIghCu+fmwT/AHe46Vn0obA6c+tUh2PpLwZpGsDQtMNtfabHLOgeK6PAIPOOB1rrPG3hbXZtAC/8I5Dq1/tBNx5waFf9raT1/CvIPhr8UtI8OaZb2GraPLP5fHnIwIHvtPT8K9Ruv2j9Js4Ei0XTri7myBh22KF9/U1g01LYhRPBtXsNdtL2W3ubaCxDkhikPlqv1OKzdUnk061jtLXUIHdRlhApO4nk5YivY9U/aD1G/wDNE3hTSbi3dsf6UqsMeh4rlbv4p6Bex7b/AOH2jAA/N5HyfyFXFt9BdTzOx1I2waXbFJcDlGZcsp9c1s2txq99bNPqmoXcOnN0YAsCfRV7V0978RNNezcaToWkaOcYVI7VZW/MisDw/pniTx/q8mnaIk2oXe0zGKNkhjUZ5JBIA61SdyvUytS0ZoFW4jsruPTsjFxKMFvfFZiTiG43QAxMOA/U19IaP+zx40v9Pht/EfiW1sLY4AgVWuWXnpngfrXlHivwhY6b8W/+EQsry4ksor23snuHUeazNtDsB7EnA+lGy1KjqcAUkkO6Q/M/ILZy1PlgijwPNLEffIXhT6V7H4U+G2lXn7QN34Hv7u6udKtWmUSrIElbbHuHI7g8H6V3UP7ONrfeH7y3tr1k1c6tJDbXMrkxpZqxw5jH3mKj15JHI61WgXPl8zSJCIeNvXp/Wo2YsxY/XivoC4+EvgrxDqEOneEvGE9pd2ck0OpQarErNAkRZWn6qFUsFABP8Y6civIvGXht/DPifVdDmlSWaxn8rz/urIp5VwOeCpBx70Xi9ExHNHr6UlS3CLHMyq4cA/eHGaioQxx6Y/WjPSvZfEXgnTvFekf2v4daK31VUD3FoDhX/wBoe9eSfY7u3vGh8qRbmNipXHIIqVJS2JTIraJp5fLjPzkcD19qc9pLFIyzo0QXgsQcCrdxGibZJY5Ipg3zlDgZ+nY1q2eqzxxxGJFaUDl5B5glX3HY1T2FdnP27MsgjjHmh+Nnqf8AGkkh2Z5wynDIw+Zf8a9F0WwstVRbiexhto5P9ZL1Uf7Xt9TU/ir4a3Gn20eoWksd7byKGRQxIIPow61CkuoKR5afwPNLG2x87Fbg8MOKlvIjFKdyhM5+UdsVD/D1plBkkY7D0oHB/pRj0NJnmgBRkkLnrWla6YZ4z5UytcJyYMfN+HrWZ6Vet4pUEM9tcqJt2VCE7196a8hM9S8N/CvVPEWnwXElxaaZL5e5Ip4ju2+pNdJo/wABIDORr/iKK2ZuEMCYBPvk0vgnxx4s0fQo5NdtBd6VDgGbOZSO2Aetekw3eg+JdBGpWlrLdySciOQ4CHv9KzlUcXYhM4LVv2f9LhiY2fjVYieB50JKn6kGuG8SfBubSLZpYfFGi3oALbUcqTT9a8R2+navqK3D3auHKi1ik3QqPXBrnT4utY4mWbQ7C4UnhyuGIprmY7voWvDfwo1XXbFbqDUNMijYnAkmwafN4Oh8Laif7U8TLbFRw9iTvJ7gHNYmq61ZTxI0Whw2u7keTMRx9BXPyTq1wzGIbG4Cu2cfjVJSbsUrvW56HafEvxHoFxv8MeKdU+wRcBb6Tzcn02nNYHiHx5quueObXxZdpbLq0DwyboYwiyNFjDEevAzXNXFwHVUjgiTaMEoM7veq3GcMCMdcUuRJ6FHsurfHnVrvU7TVbDQNE0vVondnvbaAebPuUqwcnk9c/UCmaX+0F4vsdQt7lpYZo08pGhZRho48/LnqM5OTXkUzQFAIVcN3Zj1/CoufQHNHInuNSPoHUfj9aw6Nqtt4R8I2GgXl786XqBJGVmfdIWBTDZ5AB4HHoBXmPxR8ZQ+Otct9Y/s6Oy1A2kcF86NkXUyjHm4wMZAAx6AVxgOMg5xQTuJPFUkgbEJ46UmaXrSUxHsfw48VIIYbCaPy5AMQTgcj/Z96l8a2+lavM7rcraaujfvH28Pj3HINaPjf4d3VrZjWPD/lyxgeZLbcgj1OKwtN1KaeGCHVbP7QpX5ZowBJGfQ5rB6aoxONu9bgEBgurWK5lX5d+0AuB/ePWqFrcwJFOVAkgPIt2JDIfUEdRXSeL/D0Xyy2nzSu33zwCD2wP61kvpWq6YI5NQtmgReEeVdoOegz3rW6cVYatY6f4aanaR3khguJYrgoWZXIAcegx39sYNejSRXWrQiOyuZdPjuRhvNj3JGfdR0Jryvw3DJf3RittMXzE5YxnBJ9q96+GVhJ5kcryyRXEalTbyg4H59fwrKVh21PMPEHwj1e4mizJZsrD/j7hyVI9W4HNc74i+DvinSIPPWzNzbdpYfmBr7M0yC5jnnE0FtHAQvksjBnkPfKY4H41ZuryK1l8qW2kQOM5U/KfqO1Wpj1Sufnle6Nf2Unl3FtIjA7cFT1qay8PajfIWtbaRgvDZXGDX3L4h0C21dJH/cPakAsvlhjj2PUVzmmeDtM0yZm0a4aGQfeXb5ikH1Hah1NRNs+VNN8E387qxmt0brskB6etauq+HZQsSQXumwTLxmPKs31r6e1u3hdIre80uCeEnDT2yBWU+uD0ryrxj8M9Plmd9GvpLq4lfcIHj+77ZFJT11BtswPCs2oaNZCDWbKG6tgMiWWf5CPXmpdT8WTLOkC2Vhp9ueVf7ScMvYAAVu2XhnVzBbaXqmiKttkIJ1O+Td2+X0rq4/hgtjYyyCC2lK/Mwmtgzken4UnZkK55FFBe6yGMFlpflqxxIvL7u2Djmsy+8DazfqAy3AHd5IsIp9iK970DwSk3lTjQ4lkGSrxtsKn3XFdxBomorahXubeJMcpL0H096FK2o0ne6Pn/wAC/BCxndJ/Eeqh4yvEECEHP1NenR/BzwHC0Ey6bcXJjU5izgSfU1v6Nfadpt7NZ280E9wjEyyMM7c9hXLfFrxlPp1k9qmq6e8VyNgtcEPj2Ipe1dy1qeLfGSy8J6TqNxYaRp19p93GQdo2sn0yK8r8iQp5gGQec11+qaX5tvLPqWrrBCG3eRtMjrnoOvNcreC2jISzmmkU/eLrtH5ZrSLuUiKWNEUbZd7egXpUR4GO9O42kFRnPXNOiheU4jUsfQc1VgIxS/wj+VLtYZO3gHBPbNN7npSAQ0UvekpjPqjwH4mluZJLa6aM3cWd4zncv+FWvF3gW31c/brSPyJyRIRF1H0HT6ivNbDxFZtqkctwscF2ihVuYRxN716ToviMRTwy+czQOPmVydjH29D+Fcy01Rl5Ba/ZLS1ittRjhLomAWXG/wB8VciFvIphntYp9NlX5UkARM+mccH61rX9hYeIbd/kQSD7ykYcD1FZ2k3M+isbEqrxA4EkgJiYdlYYOD7029NAt0MPTfAmkQ60brSZZoJQTvtC/H/ARj+ZrvrTQXhjLicyKItxhlXGzHo3arFho0U1z9qhjhjTbma2ZchDjqjfw/TH5Vf1Czu7WPz7S7U2xA+WTJ2/Q8/lSd+pUdRuianfNp8bKF8hCVXdkv17k9RWyPECW0P+n+WsOMkk5T61zS/bLZxPcO0jMSA8a4wPcf1qotvcmeWeLVI2ikJLRNb+YBU3aHc09V1u0eXFleWkRl/5aI5GPypkB1MWrNay2183UTKcHHoTUPlWJtnSMaZdO3DpFCIps9+TXPTaS+mSS3NjK7RO/wAsKNkx/UdxQtdb3FqX7jxLJYCb+2be1mAOHAyHX6HvXkvij4nRrqnlaItxpyFvmaZPvflXUap4n1O7mk069062t7Lot6Bk/wDAgen515vqXhfVtSuJYvD+r2d7bv8AM8TMMx/T2q4q7sxvQ7jRvC2u62YdU1DXENs43qlvdMhPof8A61HifxDrvh66h0+y1S9uI2x9xzJNEB269K8c1PQtTs3a2luZIXj6r9oOzPsK0vD3huaRRJJrj213jOFlKkj0JqnBX1asSzt7nVbDfBLFrGupqtySTJdTGNF/AGux0PXrJ7IQX8iavImd9zDOQV9c5ryLUbu4lNxp4gtLwx5DOcuxPrnFcBNFc2qylY5449+GwSFPsaFTcmJdmen+NvH1rZ6vJbaP9okSI4JL4APccdaz7z7F4h0KW71C5tbNwA20DdKPxrj9LksL60ktbuQ2h6iRIt+Mep61DP8A2NBD5Ucs9ywJ/eeXsz+tUoJbFpIivms9ga0luePlDzHIP4Cs1wmAQ7NIevGBU0UD3c5FtBI/PAjQt+lbGqaRq1rZxSalaNbWuflaUAFj+HNXsNtJ2OePXHfNWVNrHB96WSU9QPlUf41XkGGyqkL2o2tt3bTtPfFUMVnZgqvnC8AUw8cHtV6WayNkY47aQXBx+9Z+/fiqcb7XBKhwOx6GkIaevHSk4p8rmRyxx7AdhTKBnVaFqK2TSMB9oiYevK13vgbUbbV9UNhqFxLaoRuRi+I2/wDr/wCFdJD+zF44glSSHUvDKsnKkTz5B/781up+z74yAjcz+G1uV5eVbyf5z6keTWckS4nSaPodxBCBaXcbAjMfXPt9aq6zcXllJEWeO2v+FEki7oZfUMMdfftW14e+GfjnTZB59/ojxqMIFuZSU9DnyhmuyPhXXZ7Tyr+HSZ2K4Y/aXAP4eUazcX1QkjjdLvp7t2hmK2V4VAAVso3+0rdwfoKbL4oj0XUls9WuTlvl3ND19iRxXSjwJrixSW8R02K3YYULdOSn0/dfyxToPA2v/YmtbptKlj27QfOfdj3Jj5qeRlWOW1KO9u7uI6TeSi0nO5vKUnb7E5wKp3On2dqrXD32qPODgNE+1oz7DPIq6fgzrsl/LONWitATlDbXkv5FdgFXLn4W+J5rRba51HTb+HoTNLJG/wCYQ+1HIybNmSZbS6thHeaEur5GRcMTBMPfcOtVJL4WcTCDRpJETpCxIZR7OOtamn/DPx9pQNvYX2hyWP8ADHcXc7FB6A+V0roNN8CeKVA+3T6UhyOILqUqR9DGKbi9rFW6nk3jTTtPvtDlurMSaawIaQpKZkB7gpxmvCze6YdULSGdArAGezTZu+q54r6y8c/BvVvEOnTRWlxpttcN0YSuisffCVwNj+zh4tijjiu5/DUyICNwuZwx/Hya0grbkpNHltj4e07xBMLvTdYlikz8v2pdw/LNO1zwnLo0YuTqCandk4KQnAxX0Z4X+DF/pMKxzW/h8gdSryMc/jGK6SD4RaZBcG6js7Fbph8zAnH/AKDRd7CakfHNiur3lwI5blNNixhfOBUAfhW1/wAILeak6xaZdTXjScF4QSh9fwr7LtPBVsYxHf6bpUygYGU34/NauP4Ss1haO1s7a2BxgQMY8fktO+t0gaZ8bP8ABzVbVfPju3yOHVocY+nPNKvhTXLCJB5FtJJyMzQADHvX1lceCr0zh7aeJRn7skzNgd8fL1rK1X4dXjowtINMuXfILXdxIAue+0IckUrt7js+p8tX0Wty3UdirrYSEAsNPGMe+RitObwRo6qra34mvtSvU5a2PQH0yScV6rr37POqanJJcxa5Bb3MjhzHE7pEg9BhaZL+ztdvZmNptPkkZcFmuZBz3OfLJNFn00Ero+ZfFI0qC9aPTFZiPl2F8hPx7msGaV3QKS4AGCCeM19D3/7MPjKR3FnqHhyGFjnabiYn8/JpkH7LPi7ymWfVtDbrhVuZguf+/NaLY06HzqCR/wDqoIGBg/hX0Af2VfG2TjVPDmP+vmf/AOM09P2VvGew79V8O7uAMXE2P/RNAj58FFfQD/sreNi3y6r4bx73E/8A8ZpP+GVfG/8A0FfDf/gRP/8AGaasM9NtvFGrLtEmq37Jj74uHIB9OuauJ4g1Rj8mr3x473Dev161mW37P1oiJu1PUiMkZF06496B+z7aFmD6vqm3PUXbf4HFYezfcjU1W17VnJ/4mt/nJ4W4f/GkGv6mAT/a97gf9PLnPt1qin7Plh5aBtY1cjPP+lYH6ofQfnSH4AW24/8AE31Tb732N34+X9expcjte42WW8Q6oGwdZvtoOB/pDnPv19/0pF8SatuO7Vr0EcZNw+0n86rp8BrVdwe/vmXBG7+0zx74MXH/ANamn4D27q3m32ok4PTUgRz35QUODvuO5bh8Q6uSudYvDjjBuG6ce/1qwuu6sT/yFrwjI/5eG5/WqC/Aq1zkaprWM9RfREY9R8tSR/Amz+QHV9dGRtLi7iOB69OaTXZ/mG5qHVNW8zZJq16h5Kn7Q/zY4Pf1Ipo1DV8jGs37E8gfaH7fjVeT4FgK2zxNrPmEcESJgHv2qoPgRIqsr+KtbZ+cFWTafTNPldt/zAvz6rqolwNYvyB/dun5/WoZdX1jf/yF9RXHBAuX/PrVBvghcJ8g8Sa6SmArKEP+etQSfBW63DyvEuvgDjc0adfX6UuVrr+Yrm1FrOrqMLquoPjubhuf1oOsayUI/tTUFBHJ8984/OsYfBjU1LeT4s1pOAADAvGKenwk11VGPF+pLk5w1qD6Z70mn3/P/IR0cV7rkluH/tK+GeB/pD8/rT4bzWdpEupagG9p3xjv3rJt/hh4sj+RPGt0tuoGw/YwTjsCM0HwB8R4XdbfxNG8akhS9uAcevWjln0/MGzWku9YVSV1XUGbH/PZ8fzpoutZIBGq3wJOOZ3wP1rGn8HfFKMDydctZCuDg2w55+vpUEnh34tRj5b6xlIBIzbY/r14otMV0aGsXutw6ZLImr6kJMADbcyAjJ69a8N+Ini7xjp2rXEMXiXxBAijA8vUZlGQOcYb6V6hrmn/ABZgto1ure1vYJLiOJ44bchiC4HXPAHXPpXAfFjwpcQ37z36zCTeS6ocD7x6enrVx5lqx3W55k3xG8bhufGHiT8NUn/+Kqe2+I/jQk+Z4v8AEWMdTqc//wAVXOalZpA7bWOQBw3Wq1rA806xxBmLcYAySK6E0zR6nbf8LD8ZJcbR4u8RMAuc/wBpznnHT71Zx+I/jcn/AJHHxIB/2E5//iq6HwJ4M0TXLq+t9Y1O9tbqKLzofI2kOAQGByOMA5rm/Hvh+18P63c2Vldm5hjb5GZlLYx3xxnpUKUXoib62Hf8LG8b4H/FY+JP/BpP/wDF0h+I3jf/AKHLxL/4NJ//AIquVNKCAOVB/OqGfpnBHCYwwteCM5Ep6+lDxxlWxbKpzuz5p7d6dN/Zlta7pd0QChiOc9On1rJm1Pw8baO4uHaOAngurcH0IxnNcraRST6GssaFmDWwHPQyMf8AIokUfMBbNg9Ss2N1YVtqnhq4k2wTQySd0GdzYx0H9ParqzaddlhAsrCM8soxk+g5yaTkhl13fvHc5PQeaOv5UgOWO6G5Pp+871TEtoGGb2ePJ5DBgc+2fpUpk00Ll724+6cnJ46cE9P/ANdJO/X+vuHcuEtyTFOQf9sHmnl1BH7iXI7ADt0qpBJDNLmKSXyz0kZsr3/z1qZzAGKtcyEJyCuAPT8frRzdRNFeXf8Abo544Ln54/LYqQVGCTnHryasqxGMxOW5wMdaat/bDO2YYB5CnOM0q3cbTFEuFG3BKNx+Io5tdwsMmllJYi0bIxzn2/8ArmoFklYjdbvsXGAD0H+eKkutRtISXuZERVP+sPAH+elMi1SyZFaN0aNvmUg/ex6fTile7sHmOaV5Y38q3lWXGFLHgHt/WljlP3Rb3BIGCxP3jgZ/OootV063RVe7jQEcBnHPGM/X/CpW1fTQkcpu4drdDu/XHpSbQJF1Zy8Kqm4N3BPSj+0VTeshmDKevkkj/wCvVUa5pkrRpHfW6ljlQejD196srcQyQhor1WRuBtYDFUpXW4W7iRarbbQnnTDA/ihbOPyqxHqUDKD52R7xkVGZIt/lC+UEAZXeCw+tPiffkpdxP0JwQcGqTfcGhL7UYLexkna7hjVAGLuOAMjJxXhf7QFxCtteSAozKwIYHGTjgV7nqL/8Sm6MhgbETHk8cDPNeGftC3CSabKypEwO1iysMHK5/pmiTuTI+SNcnMt27MuGYnPHv0rpPAmnaMC8/ioXcVpOu2Ge34eNtyknnqNp/Q1zqW01/eiKJSz4Lk/3QOpr2e08GeJ/EvwtC6PEl5Dp0imCJQPNZSPmCnvg/pW7TtyoiTtuWrz4cQ2epST6BrY1XS5dNuJorojZJDKiqwjfHHIzxwcV4/4r1iHU7WLFvGk+QWkUYJ+UZH0yP1r1z4Oy+LvCuoa6BpF1byPaSTrbXtm+2UouDsb+9g578V4PqrvJdySSLtLuWK+hPWpinfUI2KZpeP7pNIeTTlYgYBYD61ra5R9iz+O9M07SdzaXcJPLIR5TZYkjvu/AdK5+9+Ls1zDPs0yS3bK7ZPKMmz6Djj8a4K11TQtT0kWd54g1OG2toh5cUhB81gOAeK5a21q+kuFtNCXVLiQ58qG3yx+oRRlsCuTkcnYi7PYofGdtNFCskN18ylnV1ABBbICkd/f8K7LTte0YRBTp7XDgKHnYHByM43A8nsRXz3batqdnd3UevQ6vBcACOa2e3kV0Q8gtnBXJ7d634PFX/CLRpHpM004VFULLAIiARnOSDnrQ6bQX1se+2t5oQtl377eTax2yyug/M8D8a50eMtHmuWsri8m8vPltsB2Nntv+6w7dq8k/tiw1C8k1W41q7s7llBeFIi6F+Pl9AMD2+tUjrumXV0Ynu4lADbJJPlVM9sDJz+NQ4t7lJ2PoPQvEQXzitxLBaQyeXH5ZARAe+D+VXb/Wv+Jikct5IvmJkOrDDD19Mf1rwLR9QtViJiv4DeuSnlXoJMn0wRj24yBViyuobfWopL+60i1jZMBfOYrCQepXOPelyW1HzvY9cvtYVRN5WpWwhSUBy7gnGfv8dcelbuka9YRgBddiumkILOACM9+PTrXges6hpb6kbSPW9HC8qZIlYrMD/Exzx6VqRXb2t7a2Nne2EumyKFilt5shcj5s496OUXM+p7tqFwt2JFur7T54VYHY67W/Hn/Oa838V+JLLTpftd3svEjYKsVuxRgM9vTilgc2tnFZWviPSZLlWAzNOpc47YznivOvihPcWE8U15rdvqDs/wC9gtpFKp3BOOaajd2He+p2emeIPC2om93S/Z/tB3IGfccDnPs1bS3lpHHBHDdwXVlOpYyhwXhjHP4Enr9a+d4tUtbudbW4Qi1b5UCfKVHXk02/lt4IpFgeQqW+WNPusnbJ9a09n0IvY+lf+E20WOza6vLmKIxOFiMRDARHrhfrUdr47t5o7bN8r2krMIo40wYnHTPqOc182WOu+U7RW9sUt5uWVPmljx/CD9R6Vu6ZrjqxWB7g3u05LAbAOefyqJUrDbtsfRWla7fWsxi0yK2vxI5kMc2VlLfXv1PSr8Piq7a6ktZIIbG7iyGjhG91zyAc9c/0rxDw3f6/LolsUJksYJjIrQnMquRj8qb4w8Sa7ewzR6baywhAmcKRIrDgk+uTyfrScHsNS7HtfiDxo1toer29re20U8dlJIJDgoWK/wAXoeoxXkXxT1u8vPCdjdTvYyu9vA5WBsk5QcCuAl8bXpsdRtri2iDy27rOsi8McY49+9Ov9aey8P6BcyW6SLDbxrsz1G3731A/mapU+4Ns9J+D/haK20sm6itJZtRCSNLLw0JYDC49MdfevaPDCad4EsL6CKRUmUlplmbCA4+Ur/s8V4H4B1ObVriG4sITc2wdS8Od7ou3DblH8IPevobWPClp458C29h9rkt2UAx3CDD7R/Cc9VquZ3t1El95xmjeKdb8X+M7FprmK3sms7mMRxwsY0Z48KzNnjnB5r50+K3w31fwrqDCeGa7JHmTS29uxjjJ9W7jkcmvqHwjoMvge+ez+0Xd1app007Xjv8A61kI4KAYyB3HpXjnxm+L3iHXPC6WEFvbWmmT/LKyTbpZcH+IDovFOL5ZWsPfc+dWGCQevpShVIyXxSHGM+tAJxxXUkNGpNck+UiM8iAH5ivP1r0D4C6nbaZ8SdKe+3qJI7i3UBCS7yxlUUntk9+1eZR3MkKnyyAWGCR1x6V1Hw88R3uheIrO7srm3tbqCOUQXE8YcRsy4zg98cA9s1layuTtqevaNrUc/wAT08L+LbG38MaKNJGj3MF3LuXZDJ5yM8jkbiwG0NnHzcZ7+cfFPxJH4m8canfxf8g/zfItY1PyrEg2rjA6YUfnXK+JbnVLvVri611rprudvMeS4DBpM9D8wyRWYsysykqrFeAD93FOEHuxt3NGS7aUEyu5AwpTIJA7cYqFZh5h2yBcAnJI5HpVGWVXcllBJ7rxVt7SVLMXJMZjY/Llxu/LOaVtdRpGxaajjTDbx3D+czABWPCj6/w5pwvJIbp1VoldV2mVmzkY6fSufik2q+/HzDuOv41MJxC0JIV1UZZVbIx9O1NwSBofdSlmyhfc3G4HAzWlZ3bwLHco8CyRfKoBIPHtWRq8cMV2TY3BuLdgHD7cEE9QR2wari6JxuVSB1GOv1p2ug9DXaV7y7eaPyYZiSWkD4JP49KoXdxJBNIgKFyMNKpzvqv9oXYVEUZ9GI5+lQE5PQD2FCQF61vXjl38ZweSMjNSi7ZHEok2swxlT0B7fSss9eKMHGe3rVtXRLReku3ClQdjk/MV7/jTUnCxgAMOoyD0qmeg4qRWZQHUgHOAKhoTRuaNqM1mfNglmiKc5jkxg/TuauXniS/lVme7udrn55C2ZDx/KuZEro2QAMc/Q0+5vHnK78Ngc8YzRKCvexUdiWeffuZJGYEEEN1565rf1u4ZvCmnIwAAjQZ9etcsymPkEEEdQe1XLjU57uzgs5mHkQjC4HPFDV2Nol8M+IdT8MavFqWiXT2t5GCA69weoI7ive/DH7Ss0U9uNc0mMr5e2eSBiMnHUDtnjNfPtrb2pcCaZ/mQkKg53dgapnrjp2qJ04zd+oJ9z7a8H/G7QvFMN/Jdy22nR2VlI7RTsA/PGEJ6544r5D8R3ttcajqD2E0iwzzMyIQNuwnIyexrnyPal65yccd6I02uo20xG69aSlPtSY9xWoiYqynG0hh8p46U1wUO0g8cmu11nQ9B+ym40C+ubmNAF8uQLw3di4ICj6in2Hw+1PU9GmvNP8m78pQ8sSyAuB6qR97HfAqeZEc66nGXN3PdgNdTySsgAXec4FRwyPHymPxXIrWj0WT7DcXojnaGFgpYKQM5x97GPyqlJeMLdoDEvl9FOTlT35HX8apaKw79Ck4YMdwwe/FKGIGASB1xUltbTXLqkEUkjE4ARSxP4CnraSNM8YB3p94FTkfhSKTsQKeCc/hmkJz0GKnlgVV3xuHTHOeCD9P60y3hkuZkhgTdJIQFHvTC4wOwVgCcHrSduOta974d1Cyne3ubeRbhAGZAM7Qe5IrpfDHw51fVsSSpFZ2pU/6RcOApPZVHUk0rpCbSODHYUEelex6F8EdavnlW6mtLHaTs85slvT8/WsnVfhB4hguXs7ayeW+TkBGVkmXu6NnoO9LmQuZHmOaeCemT617XpnwWjt5LF9T1H7czQGa6s7ABpIPQF87ck4qXU/h9JqGm2unaNaW41GOYiPGTMsfPEvYsPanzx2Jczw5gRjIxmgLg8g4xya9F8Q/DjxBok8sGs2E8cRORcpGWiHHUEVxx0e7aVFjRnDv5cT8BWP17UuZD5kZjZDECm4weevpWrqthDpcjW1y3mXsbASCJgyYI7MO9Os7+KGNwdPjkidQhDc5x3z602xmXE6o5LIHGDwajzzUroXJaKM7TnAHNSJaSZQyDyo2IG+TjHvijYogLFgATwOntSd6uXtvbwuwtbkXCqcZ27c+4HpVM9qaAVvTuKAMnFJSrywByPpRYR7j8Nv2fNQ8beEbLXY9ctLOG73bImgZ2GCRyQfaurX9k6/I58T2mf+vVv/iq9V/ZbkRvhDo6qeVaQHPrvNevjpQqnSxPK+58E6h4k8Ly+H4I9J8JGw8SI21MFjFs6F2Q/eb68Crnwp8Si0vxoGpE6Y91IXS5c7UeTPCsOQM5xkcdq5uy1e+n8OXkM00Ms93MW8oAGVweuGI+UfjXR+GZbi30JNN8WadbNpTLsjuJlCyQ91KyD7wz6ZrBpW1Emdb8bry3i8EfY/tNqt7b3gSSziKqyDuxVfz5zXzjciPzm8pyyZ4JGK9F8e6Nodn4ftr7TdUbULuWQiWWRslz7dDj8K816j+taUdItjitCzYSLDL5hmeJ1GVKkjn6ityxvpZIb+8R4YLsIEeXd80wPXAPf/dxXP2xhVz9pR2XHAQ4OaswwW7QytJMxcDMaKMkfWm11KsSWVtZSDdfXhiZsjCxklT2yfSoNNMMWpQG4dvs6yDe6dQueSPwqp9f0qezfZcxEGPaGDYkBKnHrjtVDPpbwjodjbWUOpaJfGXT7wlYJZ4jKHOPmQ5GQQe3Wo5PClhaX4uNS8URWSyKzsgk2sH7DngD2rm9Dn0y6sdP1LTfEw8PJFudtLiYyfZ7gjBmXcDmNueOcZrmWtPDFz4im/4SnWL9rFg0v2qLMn2qQ/xAAfIMk8EVzWvpczSPWLjxVpvheCxk1/URPcuwWC3SUSM8J/5asV4HsDXTS6xp7Wy32mzvf6YE3+dBzJk/wYHQdjXk+hR/D/Qb6YabHL4oNzGAzyhlWCPjI7fN271JeP4d0KNrz4Zahd3V7Kf9L0K7YhYh13AnGcHHGe9Q4roUvM7vTfFP9t215BotksKQTAXbMh2r6L/LrXnV5488QeHvFtzuniieCTJZEUmFe3P8VcpY6h4j1a81S1GqwaWLxjLMpdYxM2auaR8PZdX8K+ItRs78Xl3pd5DbhlfMbK/3ySfQ1tGC6kux9GeD/iZZa9ZWgN/ZXcWds4lUfKT1yp55qtrvw88B2VvqerCK8lklVpEtd7C3idumMDseeteHeGPhl4hGqQzeH9S017kIzhxMpUuvSNsnv712918XPE+ktDFY+HRKkcXkTwzwM6pdjhsHuMgkCs7WdlqvxHo0eNeKre6ttXaySCOZAxZVeLYWz7HB+lcvCZI5n2gouSrIGwfpzXReK7XxLqmqz6tr1u0N1fSNMXkZYwx9FGeMdh7Vyb53HcTu7muhbBHax7P4H8D6HrlvCuuahd6Q2wyO8ceZJY8fdC4OD05rM8ceE7HS7v8As7w2ZtYWVfNaZImlljT+Hf2U9OKpfD7xFq/hwW9xcaZc6hHOjLpoClg0mcEcckYzxVnxT498VahqMsFhYjRfOYRPBBFtZn75Y81m3K9gaOcl8O3drYYvdMaNI2Ja4wRuU9t3QEenWuRfaHbacjPGfSvQodO8V6hpcljrd6bLw8JvMubqZ1aKN+cZIPLE8YHeuAuUSO4kSJ/MjViEfGNwzwauDuUncj6HPBoFJTl9uDVjPuH9lq4Y/CnTF4VUlkUk/wC8a9mWWYg5jXqf4u2a8M/Zalm/4VXZ7RkC5dRwP7xzmvb8NziXbyeMdK5r6sqKPheCLwDplzb3dvdTXkSReXI8kgbdIRywjI4H14q1qjaZqXheWbRL57o2+N9mzkmNM8ssfb+VePxqyEP6+2ciu5+E872HiiMsjtBdwvaSKiBiVb1Uc9quS11MnFFTxJBYnQIhZ2f2adZABkAyTLjlmbJz9BwK4z8Oa9o+IltZWdvZ6Hp9lNb2tqrOJmyCG6kBx9eh6V5A1vuaRE5Knlt3FXSd07gn3IRGzK5GPl5Izz+VEULS7vLUnaNzHsB610Vj4W1B4oZorWQyuQybnURuv1zn9K2LnwzPpNnbubeON73IaSVyixEfwA5wfx60OaQ+Y4Hr2rc8P2cVzqttZTtCrSd5AcKccAkVU1GyNvNLGUYyDksCMCoIFKo0wk+cDs2CDTbTQ90dpb6OdOn1CC+huPMjk2g2zDgHpz7+lY/2PUVvHNnbyGbLKXkGfw9M/SvavDunaPq3wvh8Q6mVuNQeH7NJDJLsSWRThW7fMAPWvJNQ1eZJ7yEK9vEuFRRyyEen+NZRk3exJreEdIlXUYINbtJ5LcoUiaFwhic89P4jWZ400ye11S6eRpIblPkiZhsaRff1bFYV3q9/cX9u89yVmhwVkDYAI6Nj1r07whdWnj/T7jSPE16GurdzcQ3CptMuOzEfdHNErp3Y2mtTyaxsp7l3lfASI4YyN39Mda+sv2b9Fs4PhX/xNzFbR6zPLkuwVnUZCkA+hArzb4OeF7X/AITTWftyrMyWNxNBgbxhSMPt7/Su28IaG/ivwZNciGRdYTUCtlIN0SiBTmQJGTgfKCenenOV1ZBq3oc/H4f1nw9rE760Y4bGV2WW8jYIIWB/dNkHBzxke9bnjPUvEuo6NY2tvBaExjzI2RBuZhxvwOrEc10viaPRl0rV/wC0rZr7w4r21tbWHmMrlmx+8dxz1zg+uKf4e8PvrdpqcWjfbLVbSN7PSpbiMi4t5tmSsw6FewJ7YrFa7ITi1ofJfiuSc388N9czTTo5ysjZKN3GO1YSjPJOAK63xvp9rp+oSW7zyXWoxMRfPtwFlBwwB+tYmm2FzqTv/Z0SzSxg4gH39o6t711JpIEdt8KdY8QaVdrDo0dvemeNxHbzEHyWPWQenHXHrWH4zFzDq5F7fo0hJdxAxZUfuA3fn8qdot7faXqNi1mqRSMrRrvQho8/e+pNWvEcZfU1uFt28pcLFEFww/vM+enOTzUbSuV1Oca6mbTJLOL7V9ld/MYbiyM47msitm6vEtJZlsZpGJbJLKAM9+PSsdm3MScAk54q4+QIT0pVJB/Wk+lA4NWM+xf2YJ2h+FcQi/eMbx9yrwV5Ne5wzr5Y5Y9e+P0NeBfs03EyfDO3RFJIunIGByMmvZ45JguCR1PY1xt6sa7HxFaeDM61Z26F0tCBvmuYyBvx2H8QPtXp3hL4eW9pdzXEVwUVWDII2ySR/Fz90fSt+z8HWL3rNHc3htYlMUXmsHeMdPkPp+dbujaJLo9kIYLjJTOZx8xcE8AmnKdzHV7nJ3ngL+1Nfnk1DUmuF8ot9lkBKgnGDuqLVvhxpMdvBHMl3FHAU5t7ZGDZ64bPb1avQXiuRqYleKMW6x4LxMvmMcdCDwR9ai1e3vbmGJ/M8qObAfYhUFfTOcAewA9jUqo9imurMlvhr4bgihvLb7dG8YBEjPuWb3bbjn2FSeJ9FGp2Q0+8WCBCUdWlaMo2OjFcbh+PNbVrbXMMSxqqlimG2zYGOwGTuPHrUlzHMkjNEsbLIgUg5HH93j/GlzO+o0jwTxj8NL2zmurm7V4y5AjuPLYRyDsBxik8J/Chb/QZL3VLW8gmLfuJdypFIoPYmva9W0e/n1CG8tTFmOLDrLOrpn0CHA/Hk1kw2fid7ozNcwtp02R5Ujqp5/hRB93/AHqtVHaxOt7Hnvinw/NpWl2Ol28E15YlluGt42ABI9x3ry7xHHLa6xOyQBDG282+c+UMdGzzmvqHVF+y+G5ra9tbk+UFLqiFnODwwYdR9K8m8QaffajfT2+o6VA9vLiYSfMJ448feJH3uPWnCeo9jx25Li5W5eKIRvyAw4J9x2rpPC22BZ720eW2j8phcFGzj047LXT2nw51Fr9b3SrC4vbSVd1uz7cM3beD0XrXXL4cu205rG+8NC31Bzvd4j8gXuMZq5yTVgbujzLwl4gvdE1V73TL6VL5UbMyMCQh68Hgg1bv/iP4s1HUH1RtTnhf/ULJCixIEI2n5QMAkcZp1t4asYtS1azuN0dsr4S7GRtP930Ppiqr+HWu7wRW8qzWsZxi4UqRx1IGOtO0XrYTlY1PDHxA8U2Otzz6JffaUMaRPBdwrMJAmNoAx2xwa7/VviZ4hhmsGTVLeKeBjeOsagM0rDkSgfexnAHYYrH8EaP/AGTq2lTXkH2aYh7fc0Z2GM5+bPTPSu21HwppYY3dzCjFXJidW5m56/Ss5cu1hczZ4t4pfWPE1/capf6c6yygzhreHbHMzH7x9znNQeE/BesT3Akt7SeO5KHy5GbEbnuK+g7aws7nSsyrttwduGPQfhVHSdQg02WS3jktktrckLIpLOAein3560e00sgSZ5za+HbjSr2HVdecDUrdCHjRN5T0OOnTvXGeJoIrjTXuNOe5lub25LlAD05yT2r6WvHFxZzvFb2832lAhC43uD1GT0xWBZaZpltaNpkkcWUQlIGOQvfKkelCmt2VZpnypLZ3CzBGjcu2SoA5bHeqp64Ne4+MfDHh+2uP7Tur0XJuRtSCxb50kHTHoOOa8RuBtnlGGGGIw3Uc963jPm2HF3I80UlLVXKPqv8AZ3nkh+GUTk5AvH2rn616u1y7ncXlyfWTb+leJfAJlX4fqQQSbxtwz+XFeuW7fuhibAyere9ccleTQlLlPBPCmoags4sZ7yaQJIcmKQqIgei+59q9Ci1C4sphbm4jPlkfJI+GUHn5l6j8RXgOkanZw6pHc6ZGRuG+4jZ22JxyevFem2l7ZNbyG0keCSaH7T9p5lRyOgGc/mac1Z7ELQ9Cubu+u4Q8KEPO+VZm2gY7ehOOwrC1TWdZQyFYpYjGnWRQ4LA91XPB7VyOtazM3hqN7PVbptVuSBFaoNqlv4iGOMAjPQ5rzVL7VINRigja/Wd28yWzBbJbuQMcD86cYcxSeh9LW17qF4llqE8YLIimT5CPLJHqev5VbutUuxZGdnDhnIMkSFgR247flXjbalft5EUdxHcrIQglmSQS24PWM8BWPuBXQ29+bMSRjUHilRtpiuYWKSIB1HGPzINZ8r2QuaxvX+v6jFKYfsjzywwmRnEWVz2T3OKqaV4plnswwiJV1MccJi4Vu4PuDmvNdc8XanavP/xOroXcTBrHynBi2E88nPTJwDTNL12WbE0lzcC7mI8x9pkV274IyAT68U1DQGeujV72Dw6I2DSajE/yKM/MpPI544rHv/HenxSN9qt3eYRhZVVCCqelZthqdxDNImqCzW1EJeSWSY78n7q9Rgn1FcV4m169t9Vup4PsyyJCluba5hBIUgfKf7wx0anGN9EF7o7a08cWv2NbiIvHFeSEJFG+1kRT1I6Y4rWg8TR6vA00tzFGoRlSTzOuP6GvHNAv9Jh1COK7jRINmRMwYpGTydo6nnjFdfGtteyOI4gYbkBSUQqhj7MPT6U3BJibsanhjU9Iuru8aBPJmwwEc/zLI3crnj3FWdO8Q2ts80DrZvdLJhiqbsJ/tn+92xWDcabY6dq9vpLwyXGnJGZRPHITsbt059sVV09NDtrmWwluG3zKTKYc8ZOR9WFVuJq+x6VpWtwalKYFu5NrP5fkMg2wfQnqT/WupV7COzdGYvFb/usMMMprgLUaHFpMElpqe9UIhjeXh3k7sw7Y5rRvNe0wRv8A2jd4ijKqAnJkYdzis5LsCfc3Na+zTJApM8MGBGwgcElD3Zaj0OHTIIFihiWO1ickyg7yAP731rgtY8Z6RDdSTXKeYZyFQxsRJEPVh0xxTvDfijSILOVD85uZTHtAZnkUnO8dsChc1rjPT4tUtpmn+xvENPZNyuqZZfp+NV477S4dv7uzkIUi4lDHOD0x+lc5aeJtLDG205WSCIEyyFSVJH8RrnbvWvD+qabJFBNE17Mx2xISNoz94nuMUalN6aG+U0W41G3u9QjiRIXePdHg7UweOOvua+ZtaMJ1i+NqAIPPk8sDpt3HH6V6SPE2i2+r21xaRzJNaEwSRby0LIAQXx6+9eYX7xyX1w8AIhaRimfQniuinfqKK1K9FFFaFnv/AMFrgR+B1wcbbw5GcZyK9Qs7q2+zrvPzEkn5x6mvFPhVMieFQryqv+kk4PJ6elekWbCa2RxNCAf9ojvXLUTvoSt2kfPXhhFHmS3FqZ7CMbmboA/bdg5K11NzfwWmq20qiWGFIP3/AJJ+SViOBGp7D0x2oorWesiZKxc8O38N28cuoXkpigU/Zosgrn1BxkHFc5ea3fDxPcSG5kV41ZI5EA3bD/eJ6fjRRSh8TiHL1O10PVNPt3sYoozcXqgZmizJjIyxb1A9cVV8bancQ3JaDM6FgLVkU7ZHPXr0HXjiiioa95Ep2lY4PxA9w7xSXnlJcFcxuqeXgf3SOlTaPqr6fA9oSropDxuoO3J5ZWPfv+NFFapXRpayL8t7Nfadcz2NtLJAGxLvG8kZ4C+lYF7bnat1c5WRmAwxbKnHAJNFFEVZ2C+tjqrG10ERWdzPaTQzYP2rdPxEezL7H+tdLpGu6QgjnWCa38t9pk8wvHMDwPl7fhRRUTV1e4JXN27j0kag8yaq8MoI8tIMEqCPusD2rkm0yKTX1W2uhtluD+/UZckckhezdaKKIESXK9DsINK0e2guhYS6gzKf3omjyH9WAxwa55JL+z1UziFbO1V/KS4ni8xHJHBcetFFJaoSVyHxH4bYyebrs+6EoSZLWPGXPOcDqKv+G9O0GC1L2t7L9phh/dP95cns3HFFFKLco6jtobF+2n6VoKXqaqI9TIxMNgKMCehXHQ8Vw11Z2uo2Et1A8Me04CWh2sSfX/AUUURd9yraXOVtI3e48m8e1to4N4bACknH3N3fNcu2NxwMD0oordblIbRRRVDO98E6hb2ukbJJwkgmLbdpPGK9U0C7t59Jgkc/M27P3h/Efaiis5U1J2ZFle5//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The short axis view, with the imaging plane through the aortic root (AO) just above the aortic valve, demonstrates the left main coronary artery (LMCA). Panel B shows the M-mode echocardiogram of the LMCA.",
"    <div class=\"footnotes\">",
"     PV: pulmonary valve.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3268=[""].join("\n");
var outline_f3_12_3268=null;
var title_f3_12_3269="Mipomersen: Patient drug information";
var content_f3_12_3269=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Mipomersen: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/25/16789?source=see_link\">",
"     see \"Mipomersen: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F16128039\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Kynamro&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F16327674\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700696",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause liver problems in some patients. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194425",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You can only get this drug through the Kynamro REMS Program.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F16327676\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691406",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower cholesterol and other harmful types of cholesterol in the body.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F16327675\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194427",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to mipomersen or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F16327680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you abuse beer, wine, or mixed drinks, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F16327681\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698261",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698084",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698182",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation or swelling where the shot was given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F16327682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F16327678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694561",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Before giving the shot, bring it to room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4194430",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Give on the same day each week.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695220",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Give this drug into clean, dry, healthy skin on the belly, upper leg, or upper arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Move the site where you give the shot with each shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F16327679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3647186",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is 3 or more days to the time of your next dose, take the missed dose as soon as you think about it and go back to your normal day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3647187",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is 1 or 2 days to the time of your next dose, skip the missed dose and go back to your normal day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F16327683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F16327684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 88577 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.80.101-9C98E7F444-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3269=[""].join("\n");
var outline_f3_12_3269=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16128039\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16327674\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16327676\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16327675\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16327680\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16327681\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16327682\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16327678\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16327679\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16327683\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16327684\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/25/16789?source=related_link\">",
"      Mipomersen: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_12_3270="M mode aorta dilated CM";
var content_f3_12_3270=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    M-mode of aortic root and valve in dilated cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The M-mode echocardiogram from a normal subject (panel A) and a patient with dilated cardiomyopathy and low stroke volume (panel B) are shown. Note the difference in the cyclic anterior motion of the aortic root; the patient with low stroke volume has nearly flat root motion (panel B). Additionally, the aortic valve (Ao) has lost its \"square wave\" opening and now drifts closed as soon as it reaches its peak excursion. The valve appears more vivid in the low stroke volume patient partially because it moves less and more slowly, making it a better target for ultrasound. Also present is left atrial (LA) and right ventricular (RV) enlargement. The arrows point to reflected signals from a flow directed catheter in the patient's right ventricle outflow tract.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3270=[""].join("\n");
var outline_f3_12_3270=null;
var title_f3_12_3271="Pathology of granuloma annulare - necrobiosis";
var content_f3_12_3271=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathology of granuloma annulare - necrobiosis (H&amp;E 400x)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 424px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view at the edge of the focus of necrobiosis in the upper portion of this photomicrograph. The upper necrobiotic area shows faint basophilia representing mucinous degeneration between bundles of acellular fibrillary eosinophilic material. The rim shows numerous histiocytes and a few lymphocytes with complete mucinous degeneration of normal collagen (H&amp;E 400x).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3271=[""].join("\n");
var outline_f3_12_3271=null;
var title_f3_12_3272="Sweet syndrome plaque";
var content_f3_12_3272=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F74393%7EONC%2F61290&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F74393%7EONC%2F61290&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sweet syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A brightly erythematous plaque with a pustular component is visible on this patient with Sweet syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sweet syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 349px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A sudden, painful eruption that developed in a 50-year-old female who was febrile and had general malaise. There are multiple very edematous and erythematous papules and plaques, most of which appear vesicular or bullous on initial examination, but are firm with palpation (pseudovesiculation). However, the confluent lesions in the lower part of the picture are indeed bullous and here there is also exudation and crusting. Systems review in this patient revealed myelocytic leukemia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fitzpatrick, TB, Johnson, RA, Wolff, K, Suurmond, D. Color Atlas of Clinical Dermatology: Common and Serious Diseases. McGraw Hill, New York 2001. p.494. Copyright &copy; 2001 McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3272=[""].join("\n");
var outline_f3_12_3272=null;
var title_f3_12_3273="Renal vein thrombosis and hypercoagulable state in nephrotic syndrome";
var content_f3_12_3273=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Renal vein thrombosis and hypercoagulable state in nephrotic syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/12/3273/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/12/3273/contributors\">",
"     Jai Radhakrishnan, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/12/3273/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/12/3273/contributors\">",
"     Richard J Glassock, MD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/12/3273/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/12/3273/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/12/3273/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the nephrotic syndrome are at increased risk for venous thrombosis, particularly deep vein and renal vein thrombosis (DVT and RVT) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Pulmonary embolization (mostly asymptomatic) is relatively common, and there are case reports of cerebral venous thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Arterial thromboses (eg, limb and cerebral) also occur with higher frequency than in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/4-7\">",
"     4-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the epidemiology and pathogenesis of hypercoagulability in the nephrotic syndrome, and the clinical features and treatment of renal vein thrombosis in adults. Overviews of the nephrotic syndrome and causes of venous thrombosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/18/32041?source=see_link\">",
"     \"Overview of heavy proteinuria and the nephrotic syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link\">",
"     \"Overview of the causes of venous thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of both venous and arterial thrombosis are much higher in patients with nephrotic syndrome compared with estimates in the general population. The magnitude of this effect was illustrated in a retrospective study of 298 (predominantly adult) patients who presented with the nephrotic syndrome and were followed for a mean of 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/7\">",
"     7",
"    </a>",
"    ]. The absolute risk of venous thrombosis was 1.0 percent per year, which is eight times higher than the age- and sex-matched annual incidence reported in the Worcester DVT study [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/8\">",
"     8",
"    </a>",
"    ]. The absolute risk of arterial thrombosis was 1.5 percent per year, also approximately eight times that observed in a general population [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/9\">",
"     9",
"    </a>",
"    ]. The risk of both venous and arterial thrombosis was greatest within the first six months of diagnosis (annual incidence 9.9 and 5.5 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An increase in thromboembolic risk is also present in children with the nephrotic syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/23/25974?source=see_link&amp;anchor=H5#H5\">",
"     \"Complications of idiopathic nephrotic syndrome in children\", section on 'Thromboembolism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H131332569\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of thrombosis varies among the causes of nephrotic syndrome and appears to be highest in patients with membranous nephropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/4,10-13\">",
"     4,10-13",
"    </a>",
"    ]. This was illustrated in a cohort of 1313 patients with idiopathic glomerular disease due to membranous nephropathy, focal segmental glomerulosclerosis, or IgA nephropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/10\">",
"     10",
"    </a>",
"    ]. The incidence of venous thromboembolic events was much higher in membranous nephropathy (7.9 percent) and focal segmental glomerulosclerosis (3.0 percent) than in IgA nephropathy (0.4 percent). The histologic diagnosis remained a predictive factor for thrombosis after adjustment for the degree of proteinuria (which was much higher at presentation in membranous nephropathy and focal segmental glomerulosclerosis [median 5.6 and 3.7",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    versus 1.6",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    in IgA nephropathy]) and the serum albumin concentration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/41/37530?source=see_link&amp;anchor=H14#H14\">",
"     \"Treatment of idiopathic membranous nephropathy\", section on 'Anticoagulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with membranous nephropathy associated with lupus also appear to be at high risk for thromboembolism. In a study of 66 such patients, venous thromboembolism occurred in 15 (23 percent) at a mean follow-up of 6.9 years [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/14\">",
"     14",
"    </a>",
"    ]. Factors other than nephrotic syndrome can contribute to an increased incidence of thromboembolism in patients with lupus, such as antiphospholipid antibodies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/12/44233?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical features and therapy of membranous lupus nephritis\", section on 'Anticoagulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to the cause of nephrotic syndrome, the risk of thrombosis is also related to the severity of hypoalbuminemia and tends to occur early in the course of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/4,7,11,12,15-17\">",
"     4,7,11,12,15-17",
"    </a>",
"    ]. This is particularly true in membranous nephropathy as illustrated in a report of 898 patients with this disorder in the Glomerular Disease Collaborative Network and the Toronto Glomerulonephritis Registry [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/11\">",
"     11",
"    </a>",
"    ]. Mean proteinuria was 7.7",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    and the mean serum albumin was 2.6",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (26",
"    <span class=\"nowrap\">",
"     g/L).",
"    </span>",
"   </p>",
"   <p>",
"    The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinically evident and radiologically confirmed venous thromboembolic events occurred in 7.2 percent of patients, which is similar to the 7.9 percent incidence in the study cited in the preceding paragraph [",
"      <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The median time to the first thromboembolic event was 3.8 months; 74 percent occurred within the first two years of diagnosis and 86 percent occurred within three years.",
"     </li>",
"     <li>",
"      A low serum albumin concentration at the time of diagnosis, but not the degree of proteinuria, independently predicted a venous thromboembolic event. Compared with patients who had a serum albumin concentration greater than 2.8",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (28",
"      <span class=\"nowrap\">",
"       g/L),",
"      </span>",
"      the risk of an event was significantly higher in patients with a serum albumin concentration &le;2.8",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (28",
"      <span class=\"nowrap\">",
"       g/L)",
"      </span>",
"      &mdash; 9.4 versus 3.2 percent, adjusted relative risk 2.5. The risk increased by approximately twofold for every 1",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (10",
"      <span class=\"nowrap\">",
"       g/L)",
"      </span>",
"      reduction in serum albumin below this threshold. The duration of hypoalbuminemia (less than or more than six months) was not an independent risk factor for venous thromboembolism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In other causes of the nephrotic syndrome, which are associated with a lower risk of thromboembolism, the risk is particularly increased at a lower serum albumin (below 2.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [20",
"    <span class=\"nowrap\">",
"     g/L])",
"    </span>",
"    in some [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/15-17\">",
"     15-17",
"    </a>",
"    ] but not all studies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/4,12\">",
"     4,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The possible role of prophylactic anticoagulation in patients with nephrotic syndrome who are at increased risk for thromboembolism is discussed below. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Prophylactic anticoagulation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Renal vein thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is wide variability in the reported rate of RVT, probably related to the selection of patients for study (eg, degree of nephrotic syndrome, and symptomatic or asymptomatic thrombosis, since RVT is often clinically silent) and methods of detection (since the sensitivities of the available tests differ).",
"   </p>",
"   <p>",
"    The prevalence of RVT in patients with the nephrotic syndrome ranges from 5 to over 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/1-4,18\">",
"     1-4,18",
"    </a>",
"    ]. In studies of consecutive or unselected patients without membranous nephropathy who underwent venography, the prevalence of RVT ranges from 10 to 50 percent, most frequently due to minimal change disease, membranoproliferative glomerulonephritis, and focal segmental glomerulosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/4\">",
"     4",
"    </a>",
"    ]. A higher prevalence has been noted in patients with membranous nephropathy (20 to 60 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/4,12,13,19-21\">",
"     4,12,13,19-21",
"    </a>",
"    ]. In the largest available prospective series of 151 patients with nephrotic syndrome (mean serum albumin 2.1 to 2.4",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [21 to 24",
"    <span class=\"nowrap\">",
"     g/L]",
"    </span>",
"    and protein excretion 5.0 to 5.8",
"    <span class=\"nowrap\">",
"     g/day),",
"    </span>",
"    RVT was detected in 33 patients overall (22 percent) and in 20 of 69 patients with membranous nephropathy (29 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Deep vein thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;DVT of the extremities is the most commonly observed thromboembolic event in patients with nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. This was illustrated in a review of discharge diagnoses from hospitals in the United States from 1979 to 2005 in which 925,000 patients had a diagnosis of nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/22\">",
"     22",
"    </a>",
"    ]. Among the nephrotic patients, 14,000 (1.5 percent) were diagnosed with DVT while fewer than 5000 had RVT. The relative risk of DVT was significantly increased (1.72) in nephrotic compared to nonnephrotic patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pulmonary embolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary embolism (PE) has been described in nephrotic patients with or without an evident DVT or RVT [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/1,4,12,13,15,16,19,20,24\">",
"     1,4,12,13,15,16,19,20,24",
"    </a>",
"    ]. The estimated prevalence of asymptomatic PE in patients with the nephrotic syndrome ranges from 12 to over 30 percent, as illustrated in the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 151 consecutive nephrotic patients, 94 underwent ventilation-perfusion lung scan",
"      <span class=\"nowrap\">",
"       (V/Q",
"      </span>",
"      scan) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/12\">",
"       12",
"      </a>",
"      ]. PE was present in 12 patients (13 percent): five had a PE associated with chronic or acute RVT, and seven had an isolated PE.",
"     </li>",
"     <li>",
"      In a series of 89 nephrotic patients with a serum albumin concentration &lt;2.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (20",
"      <span class=\"nowrap\">",
"       g/L),",
"      </span>",
"      19 (21 percent) had a high probability",
"      <span class=\"nowrap\">",
"       V/Q",
"      </span>",
"      scan and, in an additional 25 patients with low or intermediate probability scans, arteriography demonstrated PE in 10 (40 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk of symptomatic PE also appears to be increased. In the review cited above of discharge diagnoses from hospitals in the United States, there was a significant 39 percent increase in PE in nephrotic compared with nonnephrotic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of the hypercoagulable state in patients with nephrotic syndrome is not well understood. Studies evaluating measures of hemostasis activation, such as the plasma level of fibrinopeptide A, which is cleaved from fibrinogen by thrombin, suggest that even asymptomatic nephrotic patients have evidence of ongoing subclinical coagulation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/25\">",
"     25",
"    </a>",
"    ]. A variety of hemostatic abnormalities have been described, including decreased levels of antithrombin and plasminogen (due to urinary losses), increased platelet activation, hyperfibrinogenemia, inhibition of plasminogen activation, and the presence of high molecular weight fibrinogen moieties in the circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/2,4,26-30\">",
"     2,4,26-30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The tendency to form thrombi at the renal vein in the nephrotic syndrome may be due in part to the loss of fluid across the glomerulus [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/4\">",
"     4",
"    </a>",
"    ]. The ensuing hemoconcentration in the postglomerular circulation, which is worsened by diuretic therapy, may promote thrombus formation in patients who are already hypercoagulable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     RENAL VEIN THROMBOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous renal vein thrombosis is rare in ambulatory individuals who are not nephrotic or without an underlying renal malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Among 218 patients who presented with renal vein thrombosis in a single center study, 143 had a malignancy (111 with renal cell carcinoma) and 43 patients had the nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some reported additional causes include trauma (including kidney biopsy), oral contraceptives, hypovolemia (especially in infants), and inherited procoagulant defects [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/31,33\">",
"     31,33",
"    </a>",
"    ]. These patients are not nephrotic, which demonstrates the important point that nephrotic syndrome is a cause, not the result, of RVT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;RVT may be unilateral or bilateral and may extend into the inferior vena cava. RVT is more often chronic, but acute RVT can occur and has a more dramatic presentation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Chronic renal vein thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;RVT most often has an insidious onset and produces no symptoms referable to the kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/12,19,20\">",
"     12,19,20",
"    </a>",
"    ]. In such patients, a pulmonary embolus is usually the only clinical clue to the possible presence of renal or other deep vein thrombosis. Abnormal ventilation-perfusion scans of the lungs indicative or suggestive of pulmonary emboli have been found in as many as 10 to 30 percent of patients with chronic RVT, most of whom are asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/1,4,12,13,15,16,19,20\">",
"     1,4,12,13,15,16,19,20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Pulmonary embolism'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    It has been suggested that a chronic RVT in patients with nephrotic syndrome may lead to increased proteinuria or progressively worsening kidney function. However, this has never been clearly documented [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/19\">",
"     19",
"    </a>",
"    ]. Furthermore, in a case report of a patient with unilateral RVT and nephrotic syndrome due to membranous nephropathy, bilateral ureteral catheterization studies showed no difference in protein excretion or creatinine clearance between the two kidneys [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Acute renal vein thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute RVT is most often due to trauma, severe dehydration (especially in infants), or a generalized hypercoagulable state. It is an uncommon complication of the nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link\">",
"     \"Overview of the causes of venous thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute RVT typically presents with symptoms of renal infarction, including flank pain, microscopic or gross hematuria, a marked elevation in serum lactate dehydrogenase (without change in transaminases), and an increase in renal size on radiographic study [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/1\">",
"     1",
"    </a>",
"    ]. Bilateral RVT can present with acute renal failure.",
"   </p>",
"   <p>",
"    Significant proteinuria is a rare complication of acute RVT in patients without underlying nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/12,35\">",
"     12,35",
"    </a>",
"    ]. In a case report, a previously healthy individual with bilateral RVT presented acutely with lower abdominal and flank pain and proteinuria (2.3 g over 24 hours); both the thrombus and proteinuria disappeared after two courses of urokinase followed by intravenous heparin [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/35\">",
"     35",
"    </a>",
"    ]. The kidney appeared normal on subsequent renal biopsy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diagnosis and screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the gold standard diagnostic test for RVT is selective renal venography (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69262 \" href=\"UTD.htm?7/63/8191\">",
"     image 1",
"    </a>",
"    ), less invasive procedures are increasingly being used, including spiral computed tomography (CT) with contrast, magnetic resonance imaging (MRI), and Doppler ultrasonography, [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/4,18,36-40\">",
"     4,18,36-40",
"    </a>",
"    ]. Institutional expertise is important in choosing a noninvasive test since false negative and false positive results have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/4,18,38,40\">",
"     4,18,38,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Routine screening for RVT is",
"    <strong>",
"     not",
"    </strong>",
"    recommended in patients with nephrotic syndrome, even in those at high-risk for RVT (eg, membranous nephropathy associated with protein excretion above 10",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a serum albumin concentration below 2",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [20",
"    <span class=\"nowrap\">",
"     g/L])",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/2\">",
"     2",
"    </a>",
"    ]. There are two problems with screening: there is no proven benefit to diagnosing occult disease, and a patient with a negative study may develop RVT at a later time, requiring sequential studies [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is also not particularly useful to evaluate for RVT in a patient who experiences an overt embolic event (such as a pulmonary embolus) for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It cannot be proven that the pulmonary embolus originated in the renal veins, since a DVT in the lower extremities may have coexisted.",
"     </li>",
"     <li>",
"      In situ pulmonary thrombosis (not an embolus) may occur in patients with severe nephrotic syndrome and profound hypoalbuminemia.",
"     </li>",
"     <li>",
"      Most important, a patient with nephrotic syndrome who has developed a thromboembolic event will be treated with anticoagulants whether or not an RVT is present.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Taking all of these factors into consideration, it is rarely necessary to image the renal veins for a thrombus in patients with the nephrotic syndrome. An important exception occurs in the rare patient suspected of having acute, complete RVT (eg, signs or symptoms of a renal infarct), which will be accompanied by acute renal failure if it is bilateral. Although a selective renal venogram is the gold standard diagnostic test and has the additional advantage of permitting a simultaneous therapeutic procedure, we suggest an initial noninvasive evaluation with CT angiography.",
"   </p>",
"   <p>",
"    A separate issue is whether chronic bilateral RVT might be a cause of a rising serum creatinine or increasing proteinuria and, if so, whether anticoagulation might be beneficial. There are no data to support this hypothesis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/19\">",
"     19",
"    </a>",
"    ]. Opinions of experts vary as to whether or not patients with marked and progressive nephrotic syndrome or a slowly rising serum creatinine should undergo an imaging procedure to screen for RVT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials to guide optimal therapy of hypercoagulability in nephrotic syndrome. There are two aspects to therapy of the hypercoagulable state in the nephrotic syndrome that must be considered: anticoagulation to prevent thromboembolic events (including RVT, DVT, and PE) and dissolution or removal of the thrombus with thrombolytic therapy or thrombectomy, which are primarily considered in patients with acute RVT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Prevention of thromboembolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three issues that must be addressed for prevention of thromboembolism in patients with the nephrotic syndrome:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prophylactic anticoagulation",
"     </li>",
"     <li>",
"      Anticoagulation for asymptomatic RVT",
"     </li>",
"     <li>",
"      Anticoagulation after a symptomatic thromboembolic event",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The goals of anticoagulation are to minimize the formation of new thrombi and to promote recanalization of the existing thrombus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Prophylactic anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The likelihood of benefit from prophylactic anticoagulation is dependent upon three factors: the incidence of thrombotic events; the ability of anticoagulation to prevent such events; and the bleeding risk associated with anticoagulation. (See",
"    <a class=\"local\" href=\"#H131332569\">",
"     'Risk factors'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42266?source=see_link&amp;anchor=H28#H28\">",
"     \"Therapeutic use of warfarin\", section on 'Bleeding'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42266?source=see_link&amp;anchor=H38#H38\">",
"     \"Therapeutic use of warfarin\", section on 'Other complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No prospective, controlled study has compared the risks associated with undiagnosed venous thrombosis with the risk of long-term anticoagulation. In a prospective uncontrolled study, 30 patients with nephrotic syndrome (14 with membranous, 13 with focal segmental glomerulosclerosis, median serum albumin 1.7",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [17",
"    <span class=\"nowrap\">",
"     g/L],",
"    </span>",
"    and median protein excretion of 9",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    were treated with low molecular weight heparin for a median of 13 months [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/41\">",
"     41",
"    </a>",
"    ]. Patients had no thromboses at baseline, as assessed by Doppler ultrasound of the renal and lower extremity veins and",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    scan of the lungs, and reassessment every three months demonstrated no thromboses throughout follow-up.",
"   </p>",
"   <p>",
"    In the absence of more convincing data, we suggest",
"    <strong>",
"     not",
"    </strong>",
"    routinely providing prophylactic anticoagulation to most patients with the nephrotic syndrome who do not have another reason for anticoagulation (eg, atrial fibrillation). Experts differ as to the ability to identify patients at high risk who might benefit from prophylactic oral anticoagulation, since randomized trials addressing this issue have not been performed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/42\">",
"     42",
"    </a>",
"    ]. However, potentially useful information is available to help with an individualized approach to prophylactic anticoagulation.",
"   </p>",
"   <p>",
"    As noted above, thromboembolic events are most common in patients with membranous nephropathy. In a study of 898 patients with membranous nephropathy, the degree of hypoalbuminemia, but not proteinuria, conferred an increased risk of venous thromboembolism [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/11\">",
"     11",
"    </a>",
"    ]. Compared with patients who had a serum albumin concentration greater than 2.8",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (28",
"    <span class=\"nowrap\">",
"     g/L),",
"    </span>",
"    the risk of an event was significantly increased in patients with a serum albumin concentration &le;2.8",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (28",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    &mdash; 9.4 versus 3.2 percent, adjusted relative risk 2.5. The risk increased by approximately twofold for every 1",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (10",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    of albumin decrease below this threshold. (See",
"    <a class=\"local\" href=\"#H131332569\">",
"     'Risk factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Because of the lack of randomized trials, the optimal approach to prophylactic anticoagulation in patients with nephrotic syndrome is not well defined. Furthermore, it is unclear if the findings in membranous nephropathy apply to other causes of nephrotic syndrome, since membranous nephropathy is associated with the highest risk of thromboembolic events and similar large series are not available for the other causes. (See",
"    <a class=\"local\" href=\"#H131332569\">",
"     'Risk factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Some experts would prophylactically anticoagulate all patients with severe nephrotic syndrome, some require an additional risk factor for thrombosis (eg, a prior idiopathic thromboembolic event, immobilization, severe heart failure, morbid obesity, abdominal, orthopedic or gynecologic surgery, or atrial fibrillation that alone does not require anticoagulation), and some do not prescribe prophylactic anticoagulation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link\">",
"     \"Overview of the causes of venous thrombosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The decision for prophylactic anticoagulation must be balanced against the risk of bleeding. Potential contraindications include advanced age, poorly controlled hypertension, a history of gastrointestinal bleeding, chronic liver disease, or intracranial disorders, and concerns about patient compliance.",
"   </p>",
"   <p>",
"    We suggest consideration of prophylactic anticoagulation in patients with nephrotic syndrome who have a serum albumin below 2.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (20",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    in all patients and 2.8",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (28",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    or less in membranous nephropathy; in both of these groups, there must be an additional risk factor for thrombosis (eg, a prior idiopathic thromboembolic event, immobilization, severe heart failure, morbid obesity, abdominal, orthopedic or gynecologic surgery, or atrial fibrillation that alone does not require anticoagulation). Patients who achieve remission of nephrotic syndrome should have anticoagulation discontinued after three to six months following remission if there is no other indication for anticoagulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Anticoagulation for asymptomatic RVT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asymptomatic RVT is detected in one of two ways: during screening, which we do not recommend, and during imaging for some other reason.",
"   </p>",
"   <p>",
"    There are no randomized trials or definitive observational studies that have evaluated the role of anticoagulation in patients with nephrotic syndrome who have an asymptomatic RVT, but case series report treating such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/12,19\">",
"     12,19",
"    </a>",
"    ]. Possible benefits include prevention of DVT or PE, while the major risk is bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An example of the difficulty in determining the proper approach comes from a poll of eight experts that we conducted. All would treat an asymptomatic RVT if it were discovered, although some with reluctance. However, only two recommend screening for RVT and only during the baseline evaluation for membranous nephropathy.",
"   </p>",
"   <p>",
"    Anticoagulation therapy should thus be provided to patients with an incidentally discovered RVT, unless contraindicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Anticoagulation for a thromboembolic event",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a symptomatic RVT (eg, acute RVT or with an associated thromboembolic event) or a thromboembolic event in the absence of RVT are treated the same as patients who have a DVT or PE. Treatment typically consists of anticoagulation, initially with unfractionated or low molecular weight heparin and then warfarin [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Some patients with nephrotic syndrome are partially resistant to heparin therapy due to severe antithrombin deficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43082?source=see_link\">",
"     \"Treatment of lower extremity deep vein thrombosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33930?source=see_link&amp;anchor=H12#H12\">",
"     \"Therapeutic use of heparin and low molecular weight heparin\", section on 'Heparin resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Duration of anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Warfarin therapy is given for a minimum of 6 to 12 months. However, most experts feel that warfarin should be continued for as long as the patient remains nephrotic [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The recommendation for prolonged therapy is similar to that in other hypercoagulable states such as an idiopathic DVT or a thromboembolic event in patients with antiphospholipid syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43082?source=see_link&amp;anchor=H26#H26\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'Idiopathic VTE'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/12/23754?source=see_link&amp;anchor=H17#H17\">",
"     \"Treatment of the antiphospholipid syndrome\", section on 'Duration of warfarin use'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The goal INR is 2.0 to 3.0. This level of anticoagulation is associated with a modest increase in risk of bleeding; a higher bleeding risk, compared with less intense therapy, is observed particularly among the elderly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Inferior vena cava filters",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with pulmonary embolism and documented renal vein thrombosis with contraindications to anticoagulation, suprarenal IVC filters have occasionally been used and are thought to be relatively safe [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Direct therapy of RVT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Fibrinolytic therapy and catheter thrombectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic fibrinolysis has been used in patients with RVT, but carries the risk of bleeding, including intracranial bleeding, and is not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/45-47\">",
"     45-47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/43/1721?source=see_link&amp;anchor=H69243077#H69243077\">",
"     \"Fibrinolytic therapy in acute ST elevation myocardial infarction: Initiation of therapy\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Successful outcomes have been reported using local thrombolytic therapy with or without extraction catheter thrombectomy in nephrotic patients with acute RVT [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/48-51\">",
"     48-51",
"    </a>",
"    ]. The potential efficacy of this approach was illustrated in a report of six patients (five of whom had proteinuric renal disease, but level of proteinuria or serum albumin not reported) with acute RVT who had percutaneous catheter thrombectomy followed by local thrombolysis for a mean of 22 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/49\">",
"     49",
"    </a>",
"    ]. Renal venous flow was restored in all patients, and the mean serum creatinine declined post-procedure from 3.3 to 1.9",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (292 to 168",
"    <span class=\"nowrap\">",
"     micromol/L).",
"    </span>",
"    At two years, kidney function was stable, and there were no further episodes of RVT.",
"   </p>",
"   <p>",
"    We favor local thrombolytic therapy with or without thrombectomy in patients who have signs of acute RVT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical thrombectomy should be considered only in the rare patient with acute bilateral RVT and acute renal failure who cannot be treated with percutaneous thrombectomy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    thrombolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3273/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the nephrotic syndrome are at increased risk for arterial and venous thrombosis, particularly deep vein thrombosis (DVT) and renal vein thrombosis (RVT). The estimated prevalence of RVT ranges from 5 to 60 percent. RVT may be unilateral or bilateral, may extend into the inferior vena cava, and may be associated with pulmonary embolism. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The risk of thrombosis is greatest in membranous nephropathy and appears to be proportional to the severity of the hypoalbuminemia. A serum albumin concentration &le;2.8",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (28",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    is the threshold level for increased risk in membranous nephropathy with a 2.13-fold increase in risk for every 1",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (10",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    decrease in albumin below this level. (See",
"    <a class=\"local\" href=\"#H131332569\">",
"     'Risk factors'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Most RVT develop insidiously and are asymptomatic. There is no clear evidence that chronic RVT leads to increased proteinuria or worsening kidney function. In contrast, acute RVT presents with signs of renal infarction. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Clinical features'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gold standard for the diagnosis of RVT is an inferior vena cavagram with selective renal venography. However, more typically, the diagnosis is made by spiral CT scanning with contrast, magnetic resonance imaging, or Doppler ultrasonography, with the choice of test based upon institutional expertise. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Diagnosis and screening'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We suggest",
"    <strong>",
"     not",
"    </strong>",
"    routinely screening for RVT in patients with the nephrotic syndrome (",
"    <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"     Grade 2C",
"    </a>",
"    ). In addition, we do not screen nephrotic patients with worsening nephrotic syndrome or slowly rising serum creatinine. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Diagnosis and screening'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In patients suspected of having acute, complete RVT because of signs or symptoms of a renal infarct or, if bilateral, acute renal failure, we suggest obtaining renal CT angiography to evaluate for both arterial and venous occlusion (",
"    <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"     Grade 2B",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Acute renal vein thrombosis'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11367?source=see_link&amp;anchor=H7#H7\">",
"     \"Diagnosis and treatment of renal infarction\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on prophylactic or therapeutic anticoagulation with warfarin (or other vitamin K antagonist) for RVT are limited. The decision to treat and choice of therapy must be individualized based upon the risks of anticoagulation, and presence of associated thromboemboli (eg, DVT or PE) or acute renal failure. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Prophylactic anticoagulation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest not providing routine prophylactic anticoagulation to patients with nephrotic syndrome (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Patients with membranous nephropathy represent the highest risk group for thromboembolism, and the risk increases progressively with serum albumin levels below 2.8",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (28",
"      <span class=\"nowrap\">",
"       g/L).",
"      </span>",
"      In such patients, we suggest prophylactic anticoagulation if there is an additional risk factor for thrombosis (eg, a prior idiopathic thromboembolic event, immobilization; severe heart failure, morbid obesity, abdominal, orthopedic or gynecologic surgery, or atrial fibrillation that alone does not require anticoagulation) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H131332569\">",
"       'Risk factors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Prophylactic anticoagulation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link\">",
"       \"Overview of the causes of venous thrombosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with causes of nephrotic syndrome other than membranous nephropathy have a lower risk of thromboembolism that in some but not all studies occurs primarily when the serum albumin is less than 2.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (20",
"      <span class=\"nowrap\">",
"       g/L).",
"      </span>",
"      In such patients, we suggest prophylactic anticoagulation if there is an additional risk factor for thrombosis (eg, a prior idiopathic thromboembolic event, immobilization, severe heart failure, morbid obesity, or abdominal, orthopedic or gynecologic surgery, or atrial fibrillation that alone does not require anticoagulation) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H131332569\">",
"       'Risk factors'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Prophylactic anticoagulation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=see_link\">",
"       \"Overview of the causes of venous thrombosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest anticoagulation therapy in patients with an incidentally discovered RVT (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We recommend anticoagulation in patients with nephrotic syndrome who have had a nonrenal thromboembolic event or acute RVT (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Anticoagulation for a thromboembolic event'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest thrombolytic therapy with or without catheter thrombectomy in patients with acute RVT (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Fibrinolytic therapy and catheter thrombectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When anticoagulation is given, we suggest that warfarin be continued for as long as the patient remains nephrotic, with a minimum duration of 6 to 12 months (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The goal INR is 2.0 to 3.0.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/1\">",
"      Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 1985; 28:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/2\">",
"      Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int 1994; 46:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/3\">",
"      Crew RJ, Radhakrishnan J, Appel G. Complications of the nephrotic syndrome and their treatment. Clin Nephrol 2004; 62:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/4\">",
"      Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res 2006; 118:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/5\">",
"      Tarry WC, Moser AJ, Makhoul RG. Peripheral arterial thrombosis in the nephrotic syndrome. Surgery 1993; 114:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/6\">",
"      Parag KB, Somers SR, Seedat YK, et al. Arterial thrombosis in nephrotic syndrome. Am J Kidney Dis 1990; 15:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/7\">",
"      Mahmoodi BK, ten Kate MK, Waanders F, et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 2008; 117:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/8\">",
"      Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151:933.",
"     </a>",
"    </li>",
"    <li>",
"     Thom, TJ, Kannel, WB, Silbershatz, H, D'Agostino, RB. Incidence, prevalence and mortality of cardiovascular diseases in the United States. In: Hurst's The Heart, 9th ed, Alexander, RW, Schlant, RC, Fuster, V (eds), McGraw-Hill, New York 1998. p3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/10\">",
"      Barbour SJ, Greenwald A, Djurdjev O, et al. Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int 2012; 81:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/11\">",
"      Lionaki S, Derebail VK, Hogan SL, et al. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol 2012; 7:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/12\">",
"      Llach F, Papper S, Massry SG. The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med 1980; 69:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/13\">",
"      Chugh KS, Malik N, Uberoi HS, et al. Renal vein thrombosis in nephrotic syndrome--a prospective study and review. Postgrad Med J 1981; 57:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/14\">",
"      Mercadal L, Montcel ST, Nochy D, et al. Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 2002; 17:1771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/15\">",
"      Cherng SC, Huang WS, Wang YF, et al. The role of lung scintigraphy in the diagnosis of nephrotic syndrome with pulmonary embolism. Clin Nucl Med 2000; 25:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/16\">",
"      Kuhlmann U, Steurer J, Bollinger A, et al. [Incidence and clinical significance of thromboses and thrombo-embolic complications in nephrotic syndrome patients]. Schweiz Med Wochenschr 1981; 111:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/17\">",
"      Waldman M, Crew RJ, Valeri A, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2007; 2:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/18\">",
"      Wei LQ, Rong ZK, Gui L, Shan RD. CT diagnosis of renal vein thrombosis in nephrotic syndrome. J Comput Assist Tomogr 1991; 15:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/19\">",
"      Wagoner RD, Stanson AW, Holley KE, Winter CS. Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int 1983; 23:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/20\">",
"      Velasquez Forero F, Garcia Prugue N, Ruiz Morales N. Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein. Am J Nephrol 1988; 8:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/21\">",
"      Liu YC, Wang HY, Pan JS. [Renal vein thrombosis in nephrotic syndrome--a prospective study of 54 cases]. Zhonghua Nei Ke Za Zhi 1989; 28:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/22\">",
"      Kayali F, Najjar R, Aswad F, et al. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med 2008; 121:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/23\">",
"      Andrassy K, Ritz E, Bommer J. Hypercoagulability in the Nephrotic syndrome. Klin Wochenschr 1980; 58:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/24\">",
"      Sarasin FP, Schifferli JA. Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int 1994; 45:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/25\">",
"      Chen TY, Huang CC, Tsao CJ. Hemostatic molecular markers in nephrotic syndrome. Am J Hematol 1993; 44:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/26\">",
"      Loscalzo J. Venous thrombosis in the nephrotic syndrome. N Engl J Med 2013; 368:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/27\">",
"      Robert A, Olmer M, Sampol J, et al. Clinical correlation between hypercoagulability and thrombo-embolic phenomena. Kidney Int 1987; 31:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/28\">",
"      Alkjaersig N, Fletcher AP, Narayanan M, Robson AM. Course and resolution of the coagulopathy in nephrotic children. Kidney Int 1987; 31:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/29\">",
"      Wakui H, Imai H, Komatsuda A, Miura AB. Circulating antibodies against alpha-enolase in patients with primary membranous nephropathy (MN). Clin Exp Immunol 1999; 118:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/30\">",
"      L&oacute;pez-Alemany R, Longstaff C, Hawley S, et al. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase. Am J Hematol 2003; 72:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/31\">",
"      Zucchelli P. Renal vein thrombosis. Nephrol Dial Transplant 1992; 7 Suppl 1:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/32\">",
"      Wysokinski WE, Gosk-Bierska I, Greene EL, et al. Clinical characteristics and long-term follow-up of patients with renal vein thrombosis. Am J Kidney Dis 2008; 51:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/33\">",
"      Wolak T, Rogachev B, Tovbin D, et al. Renal vein thrombosis as a presenting symptom of multiple genetic pro-coagulant defects. Nephrol Dial Transplant 2005; 20:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/34\">",
"      Kauffmann RH, de Graeff J, de la Rivi&egrave;re GB, van Es LA. Unilateral renal vein thrombosis and nephrotic syndrome. Report of a case with protein selectivity and antithrombin III clearance studies. Am J Med 1976; 60:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/35\">",
"      Morrissey EC, McDonald BR, Rabetoy GM. Resolution of proteinuria secondary to bilateral renal vein thrombosis after treatment with systemic thrombolytic therapy. Am J Kidney Dis 1997; 29:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/36\">",
"      Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003; 23:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/37\">",
"      Rahmouni A, Jazaerli N, Radier C, et al. Evaluation of magnetic resonance imaging for the assessment of renal vein thrombosis in the nephrotic syndrome. Nephron 1994; 68:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/38\">",
"      Tempany CM, Morton RA, Marshall FF. MRI of the renal veins: assessment of nonneoplastic venous thrombosis. J Comput Assist Tomogr 1992; 16:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/39\">",
"      Avasthi PS, Greene ER, Scholler C, Fowler CR. Noninvasive diagnosis of renal vein thrombosis by ultrasonic echo-Doppler flowmetry. Kidney Int 1983; 23:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/40\">",
"      Platt JF, Ellis JH, Rubin JM. Intrarenal arterial Doppler sonography in the detection of renal vein thrombosis of the native kidney. AJR Am J Roentgenol 1994; 162:1367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/41\">",
"      Rostoker G, Durand-Zaleski I, Petit-Phar M, et al. Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparin. Nephron 1995; 69:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/42\">",
"      Glassock RJ. Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum. J Am Soc Nephrol 2007; 18:2221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/43\">",
"      Wu CH, Ko SF, Lee CH, et al. Successful outpatient treatment of renal vein thrombosis by low-molecular weight heparins in 3 patients with nephrotic syndrome. Clin Nephrol 2006; 65:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/44\">",
"      Greenfield LJ, Cho KJ, Proctor MC, et al. Late results of suprarenal Greenfield vena cava filter placement. Arch Surg 1992; 127:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/45\">",
"      Markowitz GS, Brignol F, Burns ER, et al. Renal vein thrombosis treated with thrombolytic therapy: case report and brief review. Am J Kidney Dis 1995; 25:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/46\">",
"      Laville M, Aguilera D, Maillet PJ, et al. The prognosis of renal vein thrombosis: a re-evaluation of 27 cases. Nephrol Dial Transplant 1988; 3:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/47\">",
"      Burrow CR, Walker WG, Bell WR, Gatewood OB. Streptokinase salvage of renal function after renal vein thrombosis. Ann Intern Med 1984; 100:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/48\">",
"      Lam KK, Lui CC. Successful treatment of acute inferior vena cava and unilateral renal vein thrombosis by local infusion of recombinant tissue plasminogen activator. Am J Kidney Dis 1998; 32:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/49\">",
"      Kim HS, Fine DM, Atta MG. Catheter-directed thrombectomy and thrombolysis for acute renal vein thrombosis. J Vasc Interv Radiol 2006; 17:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/50\">",
"      Weger N, Stawicki SP, Roll G, et al. Bilateral renal vein thrombosis secondary to membraneous glomerulonephritis: successful treatment with thrombolytic therapy. Ann Vasc Surg 2006; 20:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/51\">",
"      Jaar BG, Kim HS, Samaniego MD, et al. Percutaneous mechanical thrombectomy: a new approach in the treatment of acute renal-vein thrombosis. Nephrol Dial Transplant 2002; 17:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3273/abstract/52\">",
"      Duffy JL, Letteri J, Clinque T, et al. Renal vein thrombosis and the nephrotic syndrome. Report of two cases with successful treatment of one. Am J Med 1973; 54:663.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3043 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-AA4CF5E739-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3273=[""].join("\n");
var outline_f3_12_3273=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H131332569\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Renal vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      RENAL VEIN THROMBOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Chronic renal vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Acute renal vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diagnosis and screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Prevention of thromboembolism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Prophylactic anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Anticoagulation for asymptomatic RVT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Anticoagulation for a thromboembolic event",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Duration of anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Inferior vena cava filters",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Direct therapy of RVT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Fibrinolytic therapy and catheter thrombectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3043\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3043|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/63/8191\" title=\"diagnostic image 1\">",
"      Inferior vena cavagram showing renal vein thrombosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/12/44233?source=related_link\">",
"      Clinical features and therapy of membranous lupus nephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/23/25974?source=related_link\">",
"      Complications of idiopathic nephrotic syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11367?source=related_link\">",
"      Diagnosis and treatment of renal infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/43/1721?source=related_link\">",
"      Fibrinolytic therapy in acute ST elevation myocardial infarction: Initiation of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/18/32041?source=related_link\">",
"      Overview of heavy proteinuria and the nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43786?source=related_link\">",
"      Overview of the causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33930?source=related_link\">",
"      Therapeutic use of heparin and low molecular weight heparin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/17/42266?source=related_link\">",
"      Therapeutic use of warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/41/37530?source=related_link\">",
"      Treatment of idiopathic membranous nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43082?source=related_link\">",
"      Treatment of lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/12/23754?source=related_link\">",
"      Treatment of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_12_3274="Approach to the patient with lymphocytosis or lymphocytopenia";
var content_f3_12_3274=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the patient with lymphocytosis or lymphocytopenia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/12/3274/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/12/3274/contributors\">",
"     Thomas D Coates, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/12/3274/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/12/3274/contributors\">",
"     Laurence A Boxer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/12/3274/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/12/3274/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/12/3274/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphocytes are a subset of white blood cells (WBC) that form an integral part of the immune system. They facilitate the body's humoral and cellular immunity against foreign proteins and pathogens. An increase in circulating lymphocytes (lymphocytosis) can be seen following infections such as infectious mononucleosis and pertussis, or in lymphoproliferative disorders such as acute and chronic lymphocytic leukemia. A similar array of disorders can cause a decrease in lymphocyte counts (lymphocytopenia), although immunodeficiency states must also be considered, especially in infants and young children.",
"   </p>",
"   <p>",
"    The various causes of lymphocytosis and lymphocytopenia will be reviewed here. Information on specific malignant conditions associated with abnormal lymphocyte counts (eg, chronic lymphocytic leukemia, large granular lymphocyte leukemia, acute lymphoblastic leukemia) is presented separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/38/35431?source=see_link\">",
"       \"Pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=see_link\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26007?source=see_link\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/20/30023?source=see_link\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of precursor T cell acute lymphoblastic leukemia/lymphoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/58/4009?source=see_link\">",
"       \"Overview of the presentation and classification of acute lymphoblastic leukemia in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The approach to the patient with a decrease in circulating neutrophils (neutropenia) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link\">",
"     \"Overview of neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS AND NORMAL VALUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The absolute lymphocyte count (ALC) is equal to the product of the total white blood cell count (WBC) and the percentage of lymphocytes on the WBC differential:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;ALC &nbsp;= &nbsp;WBC",
"    <span class=\"nowrap\">",
"     (cells/microL)",
"    </span>",
"    &nbsp;x &nbsp;percent lymphocytes &nbsp;&divide; &nbsp;100",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14776017\">",
"    <span class=\"h2\">",
"     Lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In individuals older than 12 years, lymphocytosis is defined as an ALC &gt;4000",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    (also expressed as",
"    <span class=\"nowrap\">",
"     &gt;4000/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    or &gt;4.0 x",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      9",
"     </sup>",
"     /L).",
"    </span>",
"    Levels of blood lymphocytes are higher in neonates and young children, who may have normal blood absolute lymphocyte counts as high as",
"    <span class=\"nowrap\">",
"     8000/microL.",
"    </span>",
"    While these definitions apply in general, increases in certain subpopulations of lymphocytes can be quite significant even though the normal value for total ALC has not been exceeded.",
"   </p>",
"   <p>",
"    When the possibility of malignancy is considered in adults, age and ALC are the best predictors of abnormal immunophenotype by flow cytometry. The ALC cutoff values are &gt;4.0 x",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      9",
"     </sup>",
"     /L",
"    </span>",
"    for patients over 67 years of age, and 6.7 x 10",
"    <sup>",
"     9",
"    </sup>",
"    <span class=\"nowrap\">",
"     cells/L",
"    </span>",
"    for patients between 50 and 67 years of age. Approximately 1.3 percent of individuals over 50 years of age will have an ALC &gt;4.0 x 10",
"    <sup>",
"     9",
"    </sup>",
"    , and 59 percent of these will have will have an abnormal immunophenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14776024\">",
"    <span class=\"h2\">",
"     Lymphocytopenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphocytopenia has been variously defined in older children and adults as an ALC &lt;1000 or &lt;1500",
"    <span class=\"nowrap\">",
"     cells/microL.",
"    </span>",
"    Infants normally have higher lymphocyte numbers, and lymphocytopenia is usually defined as an ALC &lt;2500",
"    <span class=\"nowrap\">",
"     cells/microL.",
"    </span>",
"    (See",
"    <a class=\"local\" href=\"#H24366655\">",
"     'Lymphocytopenia'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14776031\">",
"    <span class=\"h2\">",
"     Lymphocyte subpopulations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circulating blood lymphocytes include populations of T cells, B cells, and natural killer (NK) cells. Their normal relative proportions in the blood are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      T cells (eg, CD3",
"      <sup>",
"       +",
"      </sup>",
"      cells) - 60 to 80 percent",
"     </li>",
"     <li>",
"      B cells (eg, CD20",
"      <sup>",
"       +",
"      </sup>",
"      cells) - 10 to 20 percent",
"     </li>",
"     <li>",
"      NK cells (eg, CD56",
"      <sup>",
"       +",
"      </sup>",
"      cells) - 5 to 10 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The normal relative proportions of T cell subtypes in the blood are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Helper/inducer",
"      </span>",
"      T cells (ie, CD4",
"      <sup>",
"       +",
"      </sup>",
"      T cells) - 60 to 70 percent",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Suppressor/cytotoxic",
"      </span>",
"      T cells (ie, CD8",
"      <sup>",
"       +",
"      </sup>",
"      T cells) - 30 to 40 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Clonal versus reactive lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphocytosis can be either a reactive polyclonal proliferation or a clonal expansion.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Reactive lymphocytosis",
"      </strong>",
"      <strong>",
"       -",
"      </strong>",
"      This term refers to a polyclonal lymphocytosis in a patient without a history of a hematologic disorder, who has a medical condition likely to be associated with lymphocytosis, and in whom the lymphocyte count normalizes, or is expected to normalize, within less than two months after resolution of this condition. Examples are viral infection and pertussis.",
"     </li>",
"     <li>",
"      <strong>",
"       Clonal lymphocytosis",
"      </strong>",
"      - This term refers to lymphocytosis and an established diagnosis of an acute or chronic lymphoproliferative disorder. Examples are monoclonal B cell lymphocytosis (MBL), chronic lymphocytic leukemia (CLL), and lymphoproliferative disorders of large granular lymphocytes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While malignant expansions of lymphocytes are clonal, non-malignant clonal expansions of T cells and B cells are now recognized. These disorders can remain stable or can progress to malignancy. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Chronic lymphocytic leukemia'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/38/35431?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia\", section on 'Monoclonal B-cell lymphocytosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=see_link&amp;anchor=H7803413#H7803413\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia\", section on 'T cell clonopathy of unknown significance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clonality in the malignant lymphoproliferative disorders is usually determined by the presence of one or more defining abnormalities:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An abnormal",
"      <strong>",
"       karyotype",
"      </strong>",
"      characteristic of the disease in question, such as the chromosomal translocation t(12;21) seen in many cases of childhood ALL (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/25/22938?source=see_link\">",
"       \"Cytogenetics in acute lymphoblastic leukemia\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A clonal rearrangement of the immunoglobulin genes, as seen in various B cell",
"      <span class=\"nowrap\">",
"       lymphoma/leukemias",
"      </span>",
"      (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/21/6489?source=see_link\">",
"       \"General aspects of cytogenetic analysis in hematologic malignancies\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The presence of a single light chain (eg, either kappa or lambda, but not both) in the circulating lymphoid cells, as seen in B cell CLL (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/23/42361?source=see_link&amp;anchor=H3#H3\">",
"       \"Pathophysiology and genetic features of chronic lymphocytic leukemia\", section on 'Phenotype of B-CLL lymphocytes'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A clonal rearrangement of the T cell receptor, as seen in various T cell leukemias, such as T cell LGL leukemia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=see_link&amp;anchor=H458740768#H458740768\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia\", section on 'Immunophenotype'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Malignant NK cell conditions, by definition, will not show clonal rearrangements of immunoglobulin genes or the T cell receptor. However, as in aggressive NK cell leukemia, they may show Epstein-Barr virus (EBV) clonally integrated into cellular DNA [",
"      <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/3\">",
"       3",
"      </a>",
"      ]",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      may show clonal chromosomal abnormalities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6983587\">",
"    <span class=\"h1\">",
"     EVALUATION OF THE PATIENT WITH LYMPHOCYTOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete history and physical examination, together with a complete blood count and examination of the peripheral blood smear are essential for initial evaluation of the patient with lymphocytosis. In particular, one should determine if there is any history of recent infection that could explain the lymphocytosis. The differential diagnosis will depend on the age of the patient and the symptoms. In children, presence of &ldquo;atypical&rdquo; or &ldquo;viral&rdquo; lymphocytes is quite common. The presence of significant lymphadenopathy or splenomegaly is suggestive of EBV infection, even in the absence of systemic symptoms. EBV serology is indicated in most cases of lymphocytosis in children and young adults. The presence of anemia, thrombocytopenia, or neutropenia in conjunction with lymphocytosis is suggestive of a malignant process and warrants immediate referral to a hematologist. If the lymphocytosis is of moderate degree and present on repeated measurements over time, lymphocyte subset analysis should be done. Hematologic consultation should be obtained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Blood lymphocyte morphology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reactive lymphocytosis can be confused with malignant lymphocytosis (ie, the various leukemic states) by an inexperienced observer viewing the Wright-Giemsa-stained blood smear. Certain phenotypic characteristics may suggest a reactive or a malignant cause of the lymphocytosis, which could be confirmed by additional testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Reactive lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, reactive lymphocytosis is due to the presence in the peripheral blood of one of two types of lymphocytes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An absolute increase in mature normal-appearing small lymphocytes, as seen in pertussis and infectious lymphocytosis (",
"      <a class=\"graphic graphic_picture graphicRef62209 \" href=\"UTD.htm?26/9/26771\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      An absolute increase in larger lymphocytes with abundant basophilic cytoplasm and a large irregularly-shaped nucleus containing a rare nucleolus. Infectious mononucleosis during the second and third week of illness results in a marked increase in these larger forms of lymphocytes, so called \"atypical\", \"transformed\", or \"lymph variants\" (",
"      <a class=\"graphic graphic_picture graphicRef55986 \" href=\"UTD.htm?1/24/1410\">",
"       picture 2",
"      </a>",
"      ). Similar findings can be seen in the other viral illnesses listed in the table (",
"      <a class=\"graphic graphic_table graphicRef58246 \" href=\"UTD.htm?21/42/22188\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Malignant lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of different types of lymphoid cells may appear in the peripheral blood in the various malignant lymphoproliferative disorders. The early phases of B cell, T cell, or NK cell lymphoproliferative malignancies in adults can mimic benign polyclonal or reactive lymphocytosis. Bone marrow, immunophenotyping, gene rearrangement studies,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cytogenetic studies are required to differentiate chronic lymphocytic leukemia or, sometimes, T cell leukemia from benign lymphocytosis.",
"   </p>",
"   <p>",
"    Particularly in infants and very young children, normal peripheral lymphocytes can appear immature and can be mistaken for lymphoblasts by individuals not accustomed to looking at pediatric blood smears. Similarly, bone marrows of young children can contain hematogones (ie, normal maturing B cell precursors) that look immature and can be difficult to distinguish morphologically from lymphocytic leukemia blasts. They can be identified on flow cytometry. Hematogones comprise up to 6.4 percent of peripheral lymphocytes in 60 percent of infants less than one month of age [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/4\">",
"     4",
"    </a>",
"    ], and can comprise 0.01 to 1.3 percent of WBCs in adults by sensitive flow cytometry methods [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Usually by the time the patient has evidence of significant malignant lymphocytosis, there are other findings in the blood count (eg, anemia, neutropenia, thrombocytopenia) that suggest the diagnosis of leukemia. This is not always the case, especially with CLL-related disorders. Malignant disorders of lymphocytes are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/58/4009?source=see_link\">",
"     \"Overview of the presentation and classification of acute lymphoblastic leukemia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26007?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15466?source=see_link\">",
"     \"Staging and prognosis of chronic lymphocytic leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other lymphoid malignancies may have varying numbers of lymphoid cells in the peripheral blood as part of the disease process. They may be distinctive enough to suggest the underlying diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=see_link&amp;anchor=H34#H34\">",
"     \"Evaluation of the peripheral blood smear\", section on 'Worrisome findings'",
"    </a>",
"    .) These may include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lymphoblasts in acute lymphoblastic leukemia (ALL) can have varied morphologies where the blasts have essentially no cytoplasm (",
"      <a class=\"graphic graphic_picture graphicRef57831 \" href=\"UTD.htm?24/53/25439\">",
"       picture 3",
"      </a>",
"      ), abundant bluish cytoplasm (",
"      <a class=\"graphic graphic_picture graphicRef65474 \" href=\"UTD.htm?41/54/42848\">",
"       picture 4",
"      </a>",
"      ), or deep blue cytoplasm of Burkitt type lymphoblasts (",
"      <a class=\"graphic graphic_picture graphicRef57366 \" href=\"UTD.htm?38/38/39524\">",
"       picture 5",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26007?source=see_link&amp;anchor=H5#H5\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma\", section on 'Morphology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lymphocytes in splenic marginal zone lymphoma can have villous projections (",
"      <a class=\"graphic graphic_picture graphicRef59065 \" href=\"UTD.htm?35/23/36209\">",
"       picture 6",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/40/33416?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of splenic marginal zone lymphoma\", section on 'Peripheral blood'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lymphocytes in chronic lymphocytic leukemia can be small and normal appearing, often with a large proportion of damaged lymphocytes (\"smudge\" cells) (",
"      <a class=\"graphic graphic_picture graphicRef54469 \" href=\"UTD.htm?22/17/22803\">",
"       picture 7",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/38/35431?source=see_link&amp;anchor=H3#H3\">",
"       \"Pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia\", section on 'Morphology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lymphocytes in hairy cell leukemia can have with hairy projections (",
"      <a class=\"graphic graphic_picture graphicRef81031 \" href=\"UTD.htm?41/56/42884\">",
"       picture 8",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/22/20841?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical features and diagnosis of hairy cell leukemia\", section on 'Morphology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lymphocytes in LGL leukemia can be small and normal appearing or large and granular (",
"      <a class=\"graphic graphic_picture graphicRef69027 \" href=\"UTD.htm?0/1/28\">",
"       picture 9",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=see_link&amp;anchor=H113798345#H113798345\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia\", section on 'Peripheral blood'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lymphocytes in follicular lymphoma and mantle cell lymphoma can be small with cleaved nuclei (",
"      <a class=\"graphic graphic_picture graphicRef65023 \" href=\"UTD.htm?23/54/24416\">",
"       picture 10",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25322?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma\", section on 'Blood and bone marrow'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lymphocytes in mycoses fungoides can have \"cerebriform\" nuclei (ie, S&eacute;zary cells) in mycosis fungoides (",
"      <a class=\"graphic graphic_picture graphicRef75793 \" href=\"UTD.htm?10/56/11137\">",
"       picture 11",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=see_link&amp;anchor=H13602155#H13602155\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides\", section on 'Circulating S&eacute;zary cells'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CAUSES OF REACTIVE LYMPHOCYTOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual cause of reactive lymphocytosis is one of a variety of viral infections, most frequently observed in children and young adults (",
"    <a class=\"graphic graphic_table graphicRef58246 \" href=\"UTD.htm?21/42/22188\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Infectious mononucleosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epstein-Barr virus (EBV) is the major cause of infectious mononucleosis, which is associated with a marked reactive \"atypical\" lymphocytosis (",
"    <a class=\"graphic graphic_picture graphicRef55986 \" href=\"UTD.htm?1/24/1410\">",
"     picture 2",
"    </a>",
"    ). These atypical lymphocytes peak during the second and third week of illness, and persist for as long as two months [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Oral shedding of virus continues for a median of 174 days and viremia for as long as 90 days in normal college students [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=see_link&amp;anchor=H3#H3\">",
"     \"Infectious mononucleosis in adults and adolescents\", section on 'Transmission'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although EBV infects B lymphocytes, the reactive lymphocytosis in the blood is due to absolute increases in T-lymphocytes, predominately of the CD8",
"    <sup>",
"     +",
"    </sup>",
"    subtype [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=see_link\">",
"     \"Infectious mononucleosis in adults and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Mononucleosis syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;A clinical picture resembling infectious mononucleosis (mononucleosis syndrome) may be caused by a number of infectious agents other than EBV. The two most important entities to include in the differential diagnosis of the mononucleosis syndrome are infections with cytomegalovirus (CMV) and the human immunodeficiency virus (HIV-1).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cytomegalovirus (CMV), in a substantial minority of cases, causes the infectious mononucleosis syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13722?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent hosts\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      During primary infection with HIV-1, patients may present with a mononucleosis syndrome. This presentation of primary HIV infection is occasionally associated with a concomitant CMV infection [",
"      <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/11-13\">",
"       11-13",
"      </a>",
"      ]. In primary HIV the peripheral blood lymphocytosis has an immunophenotype pattern of",
"      <span class=\"nowrap\">",
"       CD3+/CD8+",
"      </span>",
"      (ie,",
"      <span class=\"nowrap\">",
"       suppressor/cytotoxic",
"      </span>",
"      T cells) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/14\">",
"       14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18151?source=see_link\">",
"       \"Acute and early HIV infection: Pathogenesis and epidemiology\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/2/13353?source=see_link\">",
"       \"The stages and natural history of HIV infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other infections have been implicated as occasional etiologies of the mononucleosis syndrome, including human herpesvirus type 6 [",
"      <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/15\">",
"       15",
"      </a>",
"      ], adenovirus type 12 [",
"      <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/16\">",
"       16",
"      </a>",
"      ], and toxoplasmosis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other viral illnesses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human T-lymphotropic virus type I (HTLV-I) infection has resulted in a self-limited immature T cell lymphocytosis as high as",
"    <span class=\"nowrap\">",
"     20,000/microL,",
"    </span>",
"    evolving into a mature T cell lymphocytosis with a",
"    <span class=\"nowrap\">",
"     CD4/CD8",
"    </span>",
"    ratio of 4.5:1 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/18\">",
"     18",
"    </a>",
"    ]. Patients with mumps, varicella, influenza, hepatitis, rubella, or measles infections usually have reactive lymphocytosis as a feature of their illness [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Infectious lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of viruses including coxsackie virus B2, poliovirus, and other enteroviruses, have been associated with a benign condition called infectious lymphocytosis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Affected patients have total white blood cell counts ranging from 20,000 to",
"    <span class=\"nowrap\">",
"     100,000/microL",
"    </span>",
"    with 60 to 90 percent small mature T-lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. The illness is often accompanied by mild eosinophilia and subsides over 4 to 10 weeks. The diagnosis is usually made by chance when a blood test is performed. Most patients are asymptomatic, although fever, respiratory signs and symptoms, diarrhea or abdominal pain, and rarely meningoencephalitis or morbilliform rash may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Pertussis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute bacterial infections rarely produce lymphocytosis, except for pertussis (whooping cough), due to infection with Bordetella pertussis. In one study of 11 children, the absolute lymphocyte count ranged from 6500 to",
"    <span class=\"nowrap\">",
"     54,800/microL,",
"    </span>",
"    with a mean of",
"    <span class=\"nowrap\">",
"     20,300/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/23\">",
"     23",
"    </a>",
"    ]. Buffy coat smears revealed a significant increase in small lymphocytes with convoluted and cleaved nuclei; mean percentages of circulating WBC were 21 percent B cells and 53 percent T cells (ie, normal percentages by immunophenotype) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/23\">",
"     23",
"    </a>",
"    ].This increase in lymphocyte numbers appears to result from a block in the normal extravasation of lymphocytes from the blood into lymph nodes rather than an increase in lymphocyte production.",
"   </p>",
"   <p>",
"    By contrast, when an identical clinical illness is caused by B. parapertussis, lymphocytosis is not observed. In one study of 114 patients, 38 of whom had B. parapertussis infection and the remainder B. pertussis, the mean leukocyte and lymphocyte counts were significantly lower in the former infection (7600 versus",
"    <span class=\"nowrap\">",
"     12,500/microL",
"    </span>",
"    and 3500 versus",
"    <span class=\"nowrap\">",
"     7800/microL,",
"    </span>",
"    respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/24\">",
"     24",
"    </a>",
"    ]. Both B. pertussis and B. parapertussis express pertussis toxin; B. pertussis also appears to produce a lymphocytosis-promoting factor toxin [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While the presence of lymphocytosis is not very specific for the diagnosis of pertussis, the absence of lymphocytosis makes pertussis unlikely [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16248?source=see_link\">",
"     \"Clinical features and diagnosis of Bordetella pertussis infection in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Cat scratch disease and other chronic bacterial infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bartonella henselae causes cat scratch disease, characterized by solitary lymphadenopathy and systemic signs and symptoms of chronic inflammation. Large atypical lymphocytes may be seen on the blood smear, usually with mild eosinophilia and monocytosis, anemia, or thrombocytopenia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/26\">",
"     26",
"    </a>",
"    ]. Other systemic chronic infections such as rickettsial infection, tuberculosis, brucellosis, and syphilis often show a similar blood picture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=see_link\">",
"     \"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Toxoplasmosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toxoplasmosis usually produces an asymptomatic infection or lymphadenopathy in immunocompetent patients, but may cause disseminated manifestations in immunocompromised hosts. The lymphadenopathy involves multiple lymph node sites and, in one-third of cases, there is associated hepatosplenomegaly. As noted above, the hematologic picture may produce the mononucleosis syndrome (ie, mimic that seen in infectious mononucleosis), with lymphocytosis and large reactive atypical lymphocytes; eosinophilia occurs in 10 to 20 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/17,27\">",
"     17,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Babesiosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Babesiosis is a tick-borne disease caused by Babesia microti in the United States; it is endemic in Martha's Vineyard, Nantucket, and Long Island. It is also caused by Babesia divergens in Europe. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/16/42248?source=see_link\">",
"     \"Epidemiology and pathogenesis of babesiosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As is true for Plasmodium parasites, Babesia infects red blood cells, causing hemolytic anemia; clinical manifestations closely resemble malaria. The organisms can be seen on blood smear (",
"    <a class=\"graphic graphic_picture graphicRef56898 \" href=\"UTD.htm?24/56/25478\">",
"     picture 12",
"    </a>",
"    ), which also reveals up to 15 percent atypical lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. However, the total white blood count is not elevated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/25/39321?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, diagnosis, treatment, and prevention of babesiosis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Non-infectious causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypersensitivity reactions and stress are the most common etiologies of non-infectious reactive lymphocytosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Hypersensitivity reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypersensitivity reactions are either drug-induced or related to acute serum sickness. Drug-induced hypersensitivity syndromes usually occur two to six weeks after starting the drug, and consist of fever, leukocytosis with eosinophilia, and atypical lymphocytosis. These reactions can progress to multi-organ failure. These reactions can be related to certain HLA types, are associated more commonly with certainly classes of drugs such as anticonvulsants, and can have a mortality of up to 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1210?source=see_link\">",
"     \"Drug allergy: Classification and clinical features\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Stress-induced lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient atypical lymphocytosis with absolute lymphocyte counts ranging from 4000 to",
"    <span class=\"nowrap\">",
"     13,000/microL,",
"    </span>",
"    often followed by neutrophilia, was observed in a group of 73 adults aged 43 to 93 years with cardiac emergencies, trauma, or status epilepticus [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/33\">",
"     33",
"    </a>",
"    ]. Their mortality rate was 50 percent, and the altered blood picture was ascribed either to stress or to administration of epinephrine. In a study of over 45,000 adult inpatients, lymphocytosis by itself, independent of trauma, predicted a threefold increased risk of death within 30 days of admission [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of lymphocytosis after trauma appears to be an early recognition sign of the high risk patient [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/35\">",
"     35",
"    </a>",
"    ]. Another emergency department study of 10 adults in sickle cell anemia crisis and 15 others with trauma or serious acute medical conditions and absolute lymphocytosis demonstrated increases in the numbers of CD20+ B cells, as well as T cells of the CD3, CD4, CD8, and CD56 phenotypes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/36\">",
"     36",
"    </a>",
"    ]. These findings mimicked the effects of parenteral epinephrine administration: a pan-B and pan-T lymphocytosis with marked increase in CD56 (four- to fivefold) and CD8 cells (three- to fourfold), as well as moderate increases in CD20 and CD4 cells (twofold) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Persistent polyclonal B cell lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A syndrome associating a polyclonal increase of B cells with binucleate lymphocytes in the peripheral blood and a polyclonal increase in serum IgM with or without splenomegaly and lymphadenopathy has been observed in young to middle-aged women who are cigarette smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/38-41\">",
"     38-41",
"    </a>",
"    ]. The median ALC is",
"    <span class=\"nowrap\">",
"     5.45/microL",
"    </span>",
"    with a range of 2.45 to",
"    <span class=\"nowrap\">",
"     20.52/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/42\">",
"     42",
"    </a>",
"    ]. The majority of cases are HLA-DR7+. The clinical course remains stable over periods of years, despite recurrent cytogenetic anomalies with an isochromosome supernumerary marker, eg, +I (3q), as well as multiple",
"    <span class=\"nowrap\">",
"     bcl-2/Ig",
"    </span>",
"    gene arrangements [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis of this condition is not known [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/44\">",
"     44",
"    </a>",
"    ]; one study has suggested a defect in the CD40 activation pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/45\">",
"     45",
"    </a>",
"    ], others suggest that the disorder is due to a uniform expansion of functional IgD+ CD27+ memory B cells of marginal zone phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/46,47\">",
"     46,47",
"    </a>",
"    ], while one suggests the presence of an underlying genetic defect [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=see_link&amp;anchor=H5#H5\">",
"     \"The humoral immune response\", section on 'Activation signals'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Postsplenectomy lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following splenectomy, most patients demonstrate an increase in circulating large granular lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. In one series of 23 patients, most of whom had Hodgkin lymphoma, splenectomy was associated with lymphocytosis in 20; the absolute lymphocyte counts ranged from 4000 to",
"    <span class=\"nowrap\">",
"     8700/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/49\">",
"     49",
"    </a>",
"    ]. The lymphocytosis persisted almost unchanged during a median follow-up of 50 months. Some patients have typical large granular lymphocyte morphology with primary expansion of NK cells [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/50\">",
"     50",
"    </a>",
"    ]. In vitro natural killer and antibody dependent cellular cytotoxic activities remain normal [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     MALIGNANT AND PREMALIGNANT LYMPHOCYTOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of malignant lymphoproliferative disorders are associated with peripheral lymphocytosis. In their early stages, it may be difficult to distinguish them from cases of reactive lymphocytosis. Serial blood counts may be necessary in order to differentiate between these two possibilities. However, the presence of blast forms (ie, lymphoblasts)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lymphocyte counts",
"    <span class=\"nowrap\">",
"     &gt;20,000/microL",
"    </span>",
"    should prompt immediate referral to a hematologist. Some of these are discussed in this section.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Thymoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral T cell lymphocytosis occurs rarely with lymphocytic thymoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. The circulating lymphocytes are not neoplastic by morphology, immunophenotyping, or gene rearrangement studies, and the cause of this association is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/52\">",
"     52",
"    </a>",
"    ]. This rare condition must be differentiated from the more common precursor T-lymphoblastic",
"    <span class=\"nowrap\">",
"     lymphoma/leukemia",
"    </span>",
"    (precursor T cell acute lymphoblastic leukemia) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lymphocytosis resolves following successful treatment of the thymoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/54\">",
"     54",
"    </a>",
"    ]. However, continued surveillance is required. In a case report, lymphocytosis developed in a 42-year-old man three years following combined chemoradiotherapy for lymphocytic thymoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H495637\">",
"    <span class=\"h2\">",
"     Hereditary polyclonal B cell lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients within the same family have presented in infancy with white cell counts in the 30,000 range with 85 percent lymphocytes and splenomegaly due to polyclonal B cells [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. The lymphocytosis persisted throughout childhood and became indistinguishable from chronic lymphocytic leukemia (CLL) by the fourth decade of life. The lymphocytosis was found to be due to a germline gain-of-function mutation of CARD11, a critical signal transducer from the cell surface antigen receptor to NF-&kappa;B pathways.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H495652\">",
"    <span class=\"h2\">",
"     Monoclonal B cell lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some asymptomatic individuals will have a monoclonal B cell expansion with fewer than 5 x 10",
"    <sup>",
"     9",
"    </sup>",
"    B",
"    <span class=\"nowrap\">",
"     cells/L",
"    </span>",
"    in the peripheral blood (ie, too few to meet the criteria for CLL) that immunophenotype similarly to CLL. Such cases may be called monoclonal B cell lymphocytosis (MBL). The incidence of MBL increases with age, from approximately 2.5 percent of the population between 40 and 60 years of age to 5 percent in people over 60 years old (ie, approximately 100 times that of CLL). The incidence of MBL is higher in healthy first-degree relatives of people with CLL [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 1 to 2 percent of cases of MBL progress to CLL per year. Disease progression is strongly related to the number of B cells, with a count of 3.7 x",
"    <span class=\"nowrap\">",
"     10",
"     <sup>",
"      9",
"     </sup>",
"     /L",
"    </span>",
"    being highly predictive of developing CLL or small lymphocytic lymphoma (SLL) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. The progression of MBL to",
"    <span class=\"nowrap\">",
"     CLL/SLL",
"    </span>",
"    does not plateau over time, and we continue to monitor these individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/38/35431?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia\", section on 'Monoclonal B-cell lymphocytosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Chronic lymphocytic leukemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic lymphocytic leukemia (CLL) is the most common leukemia, with a lifetime risk of 1 in 210 in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/59\">",
"     59",
"    </a>",
"    ]. The early phase of CLL, a mature B cell clonal lymphoproliferative malignancy, may at times pose a diagnostic dilemma in the patient with lymphocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/60\">",
"     60",
"    </a>",
"    ]. Most of the time it is possible to differentiate benign from malignant lymphocytosis on the basis of the clinical picture, physical examination, the blood film, immunophenotyping, chromosome analysis, and the detection of immunoglobulin or T cell receptor gene rearrangements. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/23/42361?source=see_link\">",
"     \"Pathophysiology and genetic features of chronic lymphocytic leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation and diagnosis of CLL is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/38/35431?source=see_link&amp;anchor=H7#H7\">",
"     \"Pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia\", section on 'Evaluation and diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hyperleukocytosis, with total white blood cell counts in excess of",
"    <span class=\"nowrap\">",
"     100,000/microL,",
"    </span>",
"    is often seen in prolymphocytic leukemia, although signs and symptoms related to leukostasis are rarely seen [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/7/19576?source=see_link\">",
"     \"Hyperleukocytosis and leukostasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Lymphoproliferative disease of large granular lymphocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphoproliferative disease of the large granular lymphocyte is a relatively rare atypical lymphocytosis characterized by the presence in the blood of",
"    <span class=\"nowrap\">",
"     &gt;2000/microL",
"    </span>",
"    large lymphocytes with slightly eccentric nuclei and abundant pale-blue cytoplasm containing many azurophilic granules (",
"    <a class=\"graphic graphic_picture graphicRef69027 \" href=\"UTD.htm?0/1/28\">",
"     picture 9",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/62\">",
"     62",
"    </a>",
"    ]. Phenotypically these cells can be divided into expansions of",
"    <span class=\"nowrap\">",
"     CD3+/CD8+/CD4-",
"    </span>",
"    T cells or",
"    <span class=\"nowrap\">",
"     CD3-/CD56+",
"    </span>",
"    NK cells that are usually clonal [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. These patients usually present in the fourth or fifth decade of life with autoimmune manifestations and neutropenia. While they can have absolute lymphocytosis, they can also have normal total lymphocytes with an increased percent of cytotoxic lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/65-67\">",
"     65-67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/46/2793?source=see_link\">",
"     \"Treatment of large granular lymphocyte leukemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20040?source=see_link\">",
"     \"Natural killer (NK) cell large granular lymphocyte leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24366655\">",
"    <span class=\"h1\">",
"     LYMPHOCYTOPENIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of lymphocytopenia (ie, an absolute lymphocyte count",
"    <span class=\"nowrap\">",
"     &lt;1000/microL",
"    </span>",
"    in older children or adults,",
"    <span class=\"nowrap\">",
"     &lt;2500/microL",
"    </span>",
"    in infants) are various and include, among others, infection, iatrogenic causes, systemic disease, and congenital immunodeficiency disorders. A partial list of these causes is presented in the table (",
"    <a class=\"graphic graphic_table graphicRef58469 \" href=\"UTD.htm?8/2/8236\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Lymphocytopenia in hospitalized patients is most frequently reversible. This was shown in a study of 1042 adults with an absolute lymphocyte count",
"    <span class=\"nowrap\">",
"     &lt;600/microL",
"    </span>",
"    who were identified over a 102-day period in a single teaching hospital. For the 698 patients who had previous and subsequent blood counts, lymphocytopenia was consistently present in only 6 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/12/3274/abstract/68\">",
"     68",
"    </a>",
"    ]. The most common causes for lymphocytopenia in this report were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bacterial or fungal sepsis: 24 percent",
"     </li>",
"     <li>",
"      Postoperative state: 22 percent",
"     </li>",
"     <li>",
"      Malignancy: 17 percent",
"     </li>",
"     <li>",
"      Use of glucocorticoids: 15 percent",
"     </li>",
"     <li>",
"      Cytotoxic chemotherapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      radiation therapy: 9 percent",
"     </li>",
"     <li>",
"      Trauma or hemorrhage: 8 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4312262\">",
"    <span class=\"h2\">",
"     Reductions in lymphocyte subsets",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to a reduction in the total number of circulating lymphocytes, a deficiency of one or more lymphocyte subsets may occur (eg, B cells, T cells, NK cells), and can be characteristic of a number of specific disorders, such as the primary or secondary immunodeficiency states. Patients with immunodeficiency may present with a range of disorders, such as:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recurrent infections",
"     </li>",
"     <li>",
"      Autoimmune disorders",
"     </li>",
"     <li>",
"      Inflammatory disorders (eg, inflammatory bowel disease, inflammatory arthritis)",
"     </li>",
"     <li>",
"      Malignancies (eg, lymphoma)",
"     </li>",
"     <li>",
"      Allergic disease (eg, atopic dermatitis, food allergy, allergic rhinosinusitis, asthma)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The approach to such patients is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link&amp;anchor=H19688153#H19688153\">",
"     \"Laboratory evaluation of the immune system\", section on 'Initial approach to the patient'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link&amp;anchor=H2#H2\">",
"     \"Laboratory evaluation of the immune system\", section on 'Defects in cellular immunity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14776038\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lymphocytes are formed elements in the blood that are an integral part of the immune system, facilitating the body's humoral and cellular immunity against foreign proteins and pathogens. An increase in circulating lymphocytes (lymphocytosis) can be either reactive (eg, infection) or clonal (eg, lymphoproliferative malignancy).",
"     </li>",
"     <li>",
"      Circulating blood lymphocytes include populations of T cells, B cells, and natural killer (NK) cells. Their normal relative proportions in the blood are 60 to 80 percent, 10 to 20 percent, and 5 to 10 percent, respectively. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definitions and normal values'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In subjects &gt;12 years of age, lymphocytosis is defined as an absolute lymphocyte count (ALC)",
"      <span class=\"nowrap\">",
"       &gt;4000/microL.",
"      </span>",
"      &nbsp;Levels of blood lymphocytes are higher in neonates and young children, who may have normal blood absolute lymphocyte counts as high as",
"      <span class=\"nowrap\">",
"       8000/microL.",
"      </span>",
"     </li>",
"     <li>",
"      The causes of reactive lymphocytosis are listed in the table (",
"      <a class=\"graphic graphic_table graphicRef58246 \" href=\"UTD.htm?21/42/22188\">",
"       table 1",
"      </a>",
"      ). The most common underlying condition leading to lymphocytosis is infection. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Causes of reactive lymphocytosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Malignant lymphoproliferative disorders are associated with peripheral lymphocytosis (",
"      <a class=\"graphic graphic_table graphicRef59978 \" href=\"UTD.htm?41/26/42412\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Malignant and premalignant lymphocytosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21337?source=see_link&amp;anchor=H8#H8\">",
"       \"Classification of the hematopoietic neoplasms\", section on 'Lymphoid neoplasms'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The morphologic appearance of the lymphocytes may help classify the patient&rsquo;s lymphocytes into reactive or malignant categories. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Blood lymphocyte morphology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lymphocytopenia has been variously defined as an ALC &lt;1000 or &lt;1500",
"      <span class=\"nowrap\">",
"       cells/microL",
"      </span>",
"      in adults and",
"      <span class=\"nowrap\">",
"       &lt;2500/microL",
"      </span>",
"      in infants. The causes of lymphocytopenia include congenital immunodeficiency disorders, infection, iatrogenic causes, and systemic disease (",
"      <a class=\"graphic graphic_table graphicRef58469 \" href=\"UTD.htm?8/2/8236\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H495977\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate would like to acknowledge Robert L Baehner, MD, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/1\">",
"      Carney D. Peripheral blood lymphocytosis--what is the threshold for further investigation? Leuk Lymphoma 2008; 49:1659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/2\">",
"      Andrews JM, Cruser DL, Myers JB, et al. Using peripheral smear review, age and absolute lymphocyte count as predictors of abnormal peripheral blood lymphocytoses diagnosed by flow cytometry. Leuk Lymphoma 2008; 49:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/3\">",
"      Kanegane H, Yachie A, Miyawaki T, Tosato G. EBV-NK cells interactions and lymphoproliferative disorders. Leuk Lymphoma 1998; 29:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/4\">",
"      Brady KA, Atwater SK, Lowell CA. Flow cytometric detection of CD10 (cALLA) on peripheral blood B lymphocytes of neonates. Br J Haematol 1999; 107:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/5\">",
"      Chantepie SP, Sala&uuml;n V, Parienti JJ, et al. Hematogones: a new prognostic factor for acute myeloblastic leukemia. Blood 2011; 117:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/6\">",
"      Sevilla DW, Colovai AI, Emmons FN, et al. Hematogones: a review and update. Leuk Lymphoma 2010; 51:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/7\">",
"      Downey H, McKinlay CA. Acute lymphadenosis compared with acute lymphatic leukemia. Arch Intern Med 1923; 32:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/8\">",
"      Vetsika EK, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med 2004; 6:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/9\">",
"      Balfour HH Jr, Odumade OA, Schmeling DO, et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 2013; 207:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/10\">",
"      Horwitz CA, Henle W, Henle G, et al. Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) 1986; 65:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/11\">",
"      Steeper TA, Horwitz CA, Hanson M, et al. Heterophil-negative mononucleosis-like illnesses with atypical lymphocytosis in patients undergoing seroconversions to the human immunodeficiency virus. Am J Clin Pathol 1988; 90:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/12\">",
"      Buchanan JG, Goldwater PN, Somerfield SD, Tobias MI. Mononucleosis-like-syndrome associated with acute AIDS retrovirus infection. N Z Med J 1986; 99:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/13\">",
"      Zambello R, Trentin L, Agostini C, et al. Persistent polyclonal lymphocytosis in human immunodeficiency virus-1-infected patients. Blood 1993; 81:3015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/14\">",
"      Cooper DA, Gold J, Maclean P, et al. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet 1985; 1:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/15\">",
"      Steeper TA, Horwitz CA, Ablashi DV, et al. The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol 1990; 93:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/16\">",
"      Horwitz CA, Henle W, Henle G, et al. Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 cases. Am J Med 1977; 63:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/17\">",
"      Remington JS. Toxoplasmosis in the adult. Bull N Y Acad Med 1974; 50:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/18\">",
"      Ehrlich GD, Han T, Bettigole R, et al. Human T-lymphotropic virus type I-associated benign transient immature T-cell lymphocytosis. Am J Hematol 1988; 27:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/19\">",
"      Shiftan TA, Mendelsohn J. The circulating \"atypical\" lymphocyte. Hum Pathol 1978; 9:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/20\">",
"      Smith CH. Infectious lymphocytosis. Am J Dis Child 1941; 62:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/21\">",
"      OLSON LC, MILLER G, HANSHAW JB. ACUTE INFECTIOUS LYMPHOCYTOSIS PRESENTING AS A PERTUSSIS-LIKE ILLNESS: ITS ASSOCIATION WITH ADENOVIRUS TYPE 12. Lancet 1964; 1:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/22\">",
"      Cassuto JP, Schneider M, Bourg M, et al. Acute infectious lymphocytosis as a T-cell lymphoproliferative syndrome. Br Med J 1977; 2:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/23\">",
"      Kubic VL, Kubic PT, Brunning RD. The morphologic and immunophenotypic assessment of the lymphocytosis accompanying Bordetella pertussis infection. Am J Clin Pathol 1991; 95:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/24\">",
"      Heininger U, Stehr K, Schmitt-Groh&eacute; S, et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994; 13:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/25\">",
"      Levene I, Wacogne I. Question 3. Is measurement of the lymphocyte count useful in the investigation of suspected pertussis in infants? Arch Dis Child 2011; 96:1203.",
"     </a>",
"    </li>",
"    <li>",
"     Margileth AM. Cat scratch disease. In: Nelson Textbook of Pediatrics, 15th ed, Behrman RE, Kliegman RM, Arvin AM (Eds), WB Saunders, Philadelphia 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/27\">",
"      Saadatnia G, Golkar M. A review on human toxoplasmosis. Scand J Infect Dis 2012; 44:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/28\">",
"      Rosenbaum GS, Johnson DH, Cunha BA. Atypical lymphocytosis in babesiosis. Clin Infect Dis 1995; 20:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/29\">",
"      Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ. Current advances in detection and treatment of babesiosis. Curr Med Chem 2012; 19:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/30\">",
"      Perkins HA, Busch MP. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion 2010; 50:2080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/31\">",
"      Pavlos R, Mallal S, Phillips E. HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics 2012; 13:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/32\">",
"      Kano Y, Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am 2009; 29:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/33\">",
"      Teggatz JR, Parkin J, Peterson L. Transient atypical lymphocytosis in patients with emergency medical conditions. Arch Pathol Lab Med 1987; 111:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/34\">",
"      Kho AN, Hui S, Kesterson JG, McDonald CJ. Which observations from the complete blood cell count predict mortality for hospitalized patients? J Hosp Med 2007; 2:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/35\">",
"      Pinkerton PH, McLellan BA, Quantz MC, Robinson JB. Acute lymphocytosis after trauma--early recognition of the high-risk patient? J Trauma 1989; 29:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/36\">",
"      Groom DA, Kunkel LA, Brynes RK, et al. Transient stress lymphocytosis during crisis of sickle cell anemia and emergency trauma and medical conditions. An immunophenotyping study. Arch Pathol Lab Med 1990; 114:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/37\">",
"      Mills PJ, Berry CC, Dimsdale JE, et al. Lymphocyte subset redistribution in response to acute experimental stress: effects of gender, ethnicity, hypertension, and the sympathetic nervous system. Brain Behav Immun 1995; 9:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/38\">",
"      Casassus P, Lortholary P, Komarover H, et al. Cigarette smoking-related persistent polyclonal B lymphocytosis. A premalignant state. Arch Pathol Lab Med 1987; 111:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/39\">",
"      Delannoy A, Djian D, Wallef G, et al. Cigarette smoking and chronic polyclonal B-cell lymphocytosis. Nouv Rev Fr Hematol 1993; 35:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/40\">",
"      Troussard X, Mossafa H, Valensi F, et al. [Polyclonal lymphocytosis with binucleated lymphocytes. Morphological, immunological, cytogenetic and molecular analysis in 15 cases]. Presse Med 1997; 26:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/41\">",
"      Lesesve JF, Troussard X. Persistent polyclonal B-cell lymphocytosis. Blood 2011; 118:6485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/42\">",
"      Cornet E, Lesesve JF, Mossafa H, et al. Long-term follow-up of 111 patients with persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes. Leukemia 2009; 23:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/43\">",
"      Delage R, Roy J, Jacques L, Darveau A. All patients with persistent polyclonal B cell lymphocytosis present Bcl-2/Ig gene rearrangements. Leuk Lymphoma 1998; 31:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/44\">",
"      Dasanu CA, Codreanu I. Persistent polyclonal B-cell lymphocytosis in chronic smokers: more than meets the eye. Conn Med 2012; 76:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/45\">",
"      Loemb&eacute; MM, Lamoureux J, Deslauriers N, et al. Lack of CD40-dependent B-cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B-cell lymphocytosis. Br J Haematol 2001; 113:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/46\">",
"      Himmelmann A, Gautschi O, Nawrath M, et al. Persistent polyclonal B-cell lymphocytosis is an expansion of functional IgD(+)CD27(+) memory B cells. Br J Haematol 2001; 114:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/47\">",
"      Salcedo I, Campos-Caro A, Sampalo A, et al. Persistent polyclonal B lymphocytosis: an expansion of cells showing IgVH gene mutations and phenotypic features of normal lymphocytes from the CD27+ marginal zone B-cell compartment. Br J Haematol 2002; 116:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/48\">",
"      Delage R, Jacques L, Massinga-Loembe M, et al. Persistent polyclonal B-cell lymphocytosis: further evidence for a genetic disorder associated with B-cell abnormalities. Br J Haematol 2001; 114:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/49\">",
"      Juneja S, Januszewicz E, Wolf M, Cooper I. Post-splenectomy lymphocytosis. Clin Lab Haematol 1995; 17:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/50\">",
"      Garcia-Suarez J, Prieto A, Reyes E, et al. Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy. Br J Haematol 1995; 89:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/51\">",
"      Kelemen E, Gergely P, Lehoczky D, et al. Permanent large granular lymphocytosis in the blood of splenectomized individuals without concomitant increase of in vitro natural killer cell cytotoxicity. Clin Exp Immunol 1986; 63:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/52\">",
"      Barton AD. T-cell lymphocytosis associated with lymphocyte-rich thymoma. Cancer 1997; 80:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/53\">",
"      Cranney A, Markman S, Lach B, Karsh J. Polymyositis in a patient with thymoma and T cell lymphocytosis. J Rheumatol 1997; 24:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/54\">",
"      Doll DC, Landreneau RJ, List AF. Malignant thymoma associated with peripheral T-cell lymphocytosis. Med Pediatr Oncol 1991; 19:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/55\">",
"      Lishner M, Ravid M, Shapira J, et al. Delta-T-lymphocytosis in a patient with thymoma. Cancer 1994; 74:2924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/56\">",
"      Snow AL, Xiao W, Stinson JR, et al. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med 2012; 209:2247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/57\">",
"      Darte JM, McClure PD, Saunders EF, et al. Congenital lymphoid hyperplasia with persistent hyperlymphocytosis. N Engl J Med 1971; 284:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/58\">",
"      Matos DM, Falc&atilde;o RP. Monoclonal B-cell lymphocytosis: a brief review for general clinicians. Sao Paulo Med J 2011; 129:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/59\">",
"      Mowery YM, Lanasa MC. Clinical aspects of monoclonal B-cell lymphocytosis. Cancer Control 2012; 19:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/60\">",
"      Macintyre EA, Linch DC. Lymphocytosis: is it leukaemia and when to treat. Postgrad Med J 1988; 64:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/61\">",
"      Berz D, Freeman NJ. Extreme hyperlymphocytosis. J Clin Oncol 2008; 26:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/62\">",
"      Sivakumaran M, Richards S. Immunological abnormalities of chronic large granular lymphocytosis. Clin Lab Haematol 1997; 19:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/63\">",
"      Kaito K, Otsubo H, Ogasawara Y, et al. Severe aplastic anemia associated with chronic natural killer cell lymphocytosis. Int J Hematol 2000; 72:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/64\">",
"      Loughran TP Jr. Clonal diseases of large granular lymphocytes. Blood 1993; 82:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/65\">",
"      Bockorny B, Dasanu CA. Autoimmune manifestations in large granular lymphocyte leukemia. Clin Lymphoma Myeloma Leuk 2012; 12:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/66\">",
"      Pontikoglou C, Kalpadakis C, Papadaki HA. Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia. Expert Rev Hematol 2011; 4:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/67\">",
"      Liu X, Loughran TP Jr. The spectrum of large granular lymphocyte leukemia and Felty's syndrome. Curr Opin Hematol 2011; 18:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/12/3274/abstract/68\">",
"      Castelino DJ, McNair P, Kay TW. Lymphocytopenia in a hospital population--what does it signify? Aust N Z J Med 1997; 27:170.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8387 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-FE77A46CF4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3274=[""].join("\n");
var outline_f3_12_3274=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14776038\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS AND NORMAL VALUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14776017\">",
"      Lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14776024\">",
"      Lymphocytopenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14776031\">",
"      Lymphocyte subpopulations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Clonal versus reactive lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6983587\">",
"      EVALUATION OF THE PATIENT WITH LYMPHOCYTOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Blood lymphocyte morphology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Reactive lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Malignant lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CAUSES OF REACTIVE LYMPHOCYTOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Infectious mononucleosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Mononucleosis syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other viral illnesses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Infectious lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Pertussis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Cat scratch disease and other chronic bacterial infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Toxoplasmosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Babesiosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Non-infectious causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Hypersensitivity reactions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Stress-induced lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Persistent polyclonal B cell lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Postsplenectomy lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      MALIGNANT AND PREMALIGNANT LYMPHOCYTOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Thymoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H495637\">",
"      Hereditary polyclonal B cell lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H495652\">",
"      Monoclonal B cell lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Chronic lymphocytic leukemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Lymphoproliferative disease of large granular lymphocytes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24366655\">",
"      LYMPHOCYTOPENIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4312262\">",
"      Reductions in lymphocyte subsets",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14776038\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H495977\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/8387\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/8387|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/9/26771\" title=\"picture 1\">",
"      Reactive lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/24/1410\" title=\"picture 2\">",
"      Atypical lymphocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/53/25439\" title=\"picture 3\">",
"      Lymphoblasts FAB L1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/54/42848\" title=\"picture 4\">",
"      Lymphoblasts FAB L2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/38/39524\" title=\"picture 5\">",
"      Burkitt lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/23/36209\" title=\"picture 6\">",
"      Villous lymphocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/17/22803\" title=\"picture 7\">",
"      CLL smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/56/42884\" title=\"picture 8\">",
"      Hairy cell leukemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/1/28\" title=\"picture 9\">",
"      Large granular lymphocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/54/24416\" title=\"picture 10\">",
"      FL with leukemic cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/56/11137\" title=\"picture 11\">",
"      Sezary cells mycosis fungoides",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/56/25478\" title=\"picture 12\">",
"      Babesia microti thin smear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/8387|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/42/22188\" title=\"table 1\">",
"      Causes of reactive lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/2/8236\" title=\"table 2\">",
"      Causes of lymphocytopenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/26/42412\" title=\"table 3\">",
"      Classification of NHL",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18151?source=related_link\">",
"      Acute and early HIV infection: Pathogenesis and epidemiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21337?source=related_link\">",
"      Classification of the hematopoietic neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16248?source=related_link\">",
"      Clinical features and diagnosis of Bordetella pertussis infection in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/22/20841?source=related_link\">",
"      Clinical features and diagnosis of hairy cell leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=related_link\">",
"      Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/25/39321?source=related_link\">",
"      Clinical manifestations, diagnosis, treatment, and prevention of babesiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21018?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26007?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/20/30023?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of precursor T cell acute lymphoblastic leukemia/lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/40/33416?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of splenic marginal zone lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25322?source=related_link\">",
"      Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/25/22938?source=related_link\">",
"      Cytogenetics in acute lymphoblastic leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1210?source=related_link\">",
"      Drug allergy: Classification and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/16/42248?source=related_link\">",
"      Epidemiology and pathogenesis of babesiosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13722?source=related_link\">",
"      Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38313?source=related_link\">",
"      Evaluation of the peripheral blood smear",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/21/6489?source=related_link\">",
"      General aspects of cytogenetic analysis in hematologic malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/7/19576?source=related_link\">",
"      Hyperleukocytosis and leukostasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=related_link\">",
"      Infectious mononucleosis in adults and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=related_link\">",
"      Laboratory evaluation of the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=related_link\">",
"      Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/36/20040?source=related_link\">",
"      Natural killer (NK) cell large granular lymphocyte leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=related_link\">",
"      Overview of neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/58/4009?source=related_link\">",
"      Overview of the presentation and classification of acute lymphoblastic leukemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/38/35431?source=related_link\">",
"      Pathologic features, diagnosis, and differential diagnosis of chronic lymphocytic leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/23/42361?source=related_link\">",
"      Pathophysiology and genetic features of chronic lymphocytic leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/6/15466?source=related_link\">",
"      Staging and prognosis of chronic lymphocytic leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=related_link\">",
"      The humoral immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/2/13353?source=related_link\">",
"      The stages and natural history of HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/46/2793?source=related_link\">",
"      Treatment of large granular lymphocyte leukemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_12_3275="Sx of hyperparathyroidism";
var content_f3_12_3275=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F69796&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F69796&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Symptoms and signs of excess parathyroid hormone secretion",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Symptoms and signs of hypercalcemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nephrolithiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypophosphatemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased production of calcitriol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Proximal renal tubular acidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypomagnesemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperuricemia and gout",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anemia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3275=[""].join("\n");
var outline_f3_12_3275=null;
var title_f3_12_3276="Medicines for treating atrial fibrillation PI";
var content_f3_12_3276=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F86624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F86624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Medicines for treating atrial fibrillation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type of medicine",
"       </td>",
"       <td class=\"subtitle1\">",
"        Generic name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sample US brand names",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Heart rhythm control medicines",
"       </td>",
"       <td>",
"        Amiodarone",
"       </td>",
"       <td>",
"        Cordarone, Nexterone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dofetilide",
"       </td>",
"       <td>",
"        Tikosyn",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Flecainide",
"       </td>",
"       <td>",
"        Tambocor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Propafenone",
"       </td>",
"       <td>",
"        Rythmol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sotalol",
"       </td>",
"       <td>",
"        Betapace AF, Sorine",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        Heart rate control medicines",
"       </td>",
"       <td>",
"        Digoxin",
"       </td>",
"       <td>",
"        Lanoxin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diltiazem",
"       </td>",
"       <td>",
"        Cardizem, Dilacor XR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Verapamil",
"       </td>",
"       <td>",
"        Calan, Isoptin SR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metoprolol",
"       </td>",
"       <td>",
"        Lopressor, Toprol-XL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Propranolol",
"       </td>",
"       <td>",
"        Inderal LA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Esmolol",
"       </td>",
"       <td>",
"        Brevibloc",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Anti-clotting medicines",
"       </td>",
"       <td>",
"        Warfarin",
"       </td>",
"       <td>",
"        Coumadin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dabigatran",
"       </td>",
"       <td>",
"        Pradaxa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rivaroxaban",
"       </td>",
"       <td>",
"        Xarelto",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3276=[""].join("\n");
var outline_f3_12_3276=null;
var title_f3_12_3277="Cause prim adrenal insufficienc";
var content_f3_12_3277=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of primary adrenal insufficiency in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Steroidogenesis disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Congenital adrenal hyperplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        CYP21A2 (21-hydroxylase) deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        CYP11B1 (11-beta-hydroxylase) deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        CYP17 (17-alpha-hydroxylase) deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3-beta-hydroxysteroid dehydrogenase deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        CYP11A or StAR deficiency (congenital lipoid adrenal hyperplasia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        P450 oxidoreductase (POR) deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Defects in aldosterone production",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        CYP11B2 (aldosterone synthase) deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Defects in cholesterol biochemistry",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lysosomal acid lipase deficiency (Wolman disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Smith-Lemli-Opitz syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Damage to otherwise normal adrenal glands",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bilateral adrenal hemorrhage of the newborn",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adrenal hemorrhage of acute infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kearns-Sayre syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Autoimmunity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Polyglandular autoimmune syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tuberculosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Fungal infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Human immunodeficiency virus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cytomegalovirus (CMV)&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Aminoglutethimide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ketoconazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Etomidate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Peroxisomal defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        X-linked Adrenoleukodystrophy/Adrenomyeloneuropathy (ALD/AMN)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neonatal Adrenoleukodystrophy (autosomal recessive)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Refsum disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zellweger syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Abnormal adrenal development",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        X-linked adrenal hypoplasia congenita (AHC) due to DAX-1 defect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adrenal hypoplasia due to steroidogenic factor-1 (SF-1) defect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IMAGe syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Unresponsive to ACTH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Familial glucocorticoid deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Triple A syndrome (Allgrove syndrome)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Patricia Donohoue, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3277=[""].join("\n");
var outline_f3_12_3277=null;
var title_f3_12_3278="Contents: Gastroenterology and Hepatology";
var content_f3_12_3278=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      Gastroenterology and Hepatology",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Gastroenterology and Hepatology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     You receive the entire UpToDate library of specialties with your ",
"							subscription. Click on a section below to view a detailed list of topics associated ",
"							with that particular section. If you'd like to see the table of contents for other ",
"							specialties,",
"     <a href=\"UTD.htm?3/3/3134\">",
"      click here",
"     </a>",
"     .",
"     <br/>",
"     <br/>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"UTD.htm?38/38/39534\">",
"         Acid peptic disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?4/20/4431\">",
"         Biliary tract disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?4/25/4511\">",
"         Cirrhosis",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?9/0/9231\">",
"         Endocrine tumors",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?2/36/2639\">",
"         Esophageal disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?10/20/10574\">",
"         Gastroenterology and Hepatology calculators",
"        </a>",
"        <br/>",
"       </tds>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"UTD.htm?20/10/20642\">",
"         Gastrointestinal cancer",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?40/18/41249\">",
"         Gastrointestinal disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?0/4/73\">",
"         Gastrointestinal endoscopy",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?4/60/5071\">",
"         Gastrointestinal infections",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?16/56/17280\">",
"         Hepatic disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?3/38/3680\">",
"         Hepatitis",
"        </a>",
"        <br/>",
"       </tds>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"UTD.htm?18/16/18703\">",
"         Inflammatory bowel disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?18/53/19294\">",
"         Liver transplantation",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?4/32/4622\">",
"         Malabsorption syndromes",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?36/44/37582\">",
"         Pancreatic disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?43/3/44086\">",
"         What's new in gastroenterology and hepatology",
"        </a>",
"        <br/>",
"       </tds>",
"      </trs>",
"      <trs>",
"       <tds>",
"        &nbsp;",
"       </tds>",
"      </trs>",
"      <trs>",
"       <tds>",
"        <a class=\"tocItem\" href=\"UTD.htm?18/22/18798\">",
"         Patient Information",
"        </a>",
"        <br/>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-2D8C0831B2-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f3_12_3278=[""].join("\n");
var outline_f3_12_3278=null;
var title_f3_12_3279="Tooth aspiration";
var content_f3_12_3279=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tooth aspiration",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 388px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph (left) obtained following trauma in a 28-year-old man shows a radiopaque foreign body in the right lower lobe. A fractured tooth (right) was removed bronchoscopically.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles Marquette, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_12_3279=[""].join("\n");
var outline_f3_12_3279=null;
       